Pollen allergy

POLLENALLERG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J30.10, J30.19 Cause of death: ICD-10 — J30.10, J30.19 2 out of 7 registries used, show all original rules.	9532
4. Check minimum number of events None	9532
5. Include endpoints None	9532
6. Filter based on genotype QC (FinnGen only)	9083

Control definitions (FinnGen only)

Control exclude: ASTHMA_ALLERG

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	POLLENALLERG
CONTROL_EXCLUDE	ASTHMA_ALLERG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pollen allergy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	108129	50206	57693
Only index persons	94109	45353	48756
Unadjusted period prevalence (%)
Whole population	1.53	1.44	1.61
Only index persons	1.77	1.67	1.86
Median age at first event (years)
Whole population	14.16	17.11	11.52
Only index persons	16.22	19.74	12.94

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9083	6229	2854
Unadjusted period prevalence (%)	1.93	2.21	1.31
Median age at first event (years)	31.26	32.26	29.08

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9524: Matched controls
94010

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

7.5

320.7

474

653

R01AD09

ATC

mometasone; nasal

3.9

307.7

6521

33360

J45

ICD-10 Finland

Asthma

4.6

307.7

1890

4768

R01AD58

ATC

fluticasone, combinations; nasal

3.3

307.7

4290

18529

E0000UV, ,

ATC

2.4

307.7

4928

29324

Z51.6

ICD-10 Finland

Desensitization to allergens

244.0

307.7

1995

102

V01AA05

ATC

tree pollen; parenteral

32.1

307.7

715

237

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

6.1

307.7

2419

4947

XG474

NOMESCO Finland

Exhalation nntrogen oxide

9.8

307.7

797

870

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.9

307.7

1865

5525

R01AD01

ATC

beclometasone; nasal

3.1

307.7

1981

7274

R01AC01

ATC

cromoglicic acid; nasal

5.4

307.7

955

1899

T78.4

ICD-10 Finland

Allergy, unspecified

4.3

307.7

1012

2534

R01AD11

ATC

triamcinolone; nasal

3.6

307.7

1245

3817

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

5.0

307.7

945

2044

J30.3

ICD-10 Finland

Other allergic rhinitis

11.6

307.7

1529

1521

R06AX27

ATC

desloratadine; oral

4.8

307.7

5742

22414

R03BA01

ATC

beclometasone; inhalant

3.3

307.7

1697

5734

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

622.4

307.7

8983

2443

S01GX02

ATC

levocabastine; ophthalmic

5.0

307.7

1271

2807

R03BA08

ATC

ciclesonide; inhalant

3.7

307.7

1256

3662

C01CA24

ATC

epinephrine; parenteral

10.9

307.7

2643

3207

R06AX26

ATC

fexofenadine; oral

4.6

307.7

1416

3433

R96

ICPC

Asthma

4.3

307.7

1436

3759

R01AD05

ATC

budesonide; nasal

4.9

307.7

1314

2983

R03DC03

ATC

montelukast; oral

5.9

307.7

3679

9018

J45.0

ICD-10 Finland

Predominantly allergic asthma

17.0

307.7

3815

3564

J45.9

ICD-10 Finland

Asthma, unspecified

5.0

307.7

3255

8794

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.2

307.7

1000

1758

WQ000

NOMESCO Finland

Hyposensibilisation

216.9

307.7

860

R03AC02

ATC

salbutamol; inhalant

5.9

307.7

7737

39913

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

307.7

355

A92

ICPC

Allergy/allergic reaction NOS

4.8

307.7

840

1851

R06AX22

ATC

ebastine; oral

4.3

307.7

3133

9552

R01AD12

ATC

fluticasone furoate; nasal

3.0

307.7

4882

24609

XG410

NOMESCO Finland

Flow-volume spirometry

8.3

307.7

812

1040

R06AX13

ATC

loratadine; oral

4.3

307.7

3089

9412

S01GX08

ATC

ketotifen; ophthalmic

5.0

307.7

1005

2162

R01BA52

ATC

pseudoephedrine, combinations; oral

2.5

307.7

2935

14423

R03AK07

ATC

formoterol and budesonide; inhalant

3.0

307.7

2866

11724

H02AB06

ATC

prednisolone; systemic

3.5

307.7

5503

26207

R06AE09

ATC

levocetirizine; oral

4.8

307.7

3177

8891

J30.19

ICD-10 Finland

Pollen allergy UNS

6.8

307.7

1519

2550

L20.0

ICD-10 Finland

Besnier prurigo

4.4

307.7

2137

5762

SPAT1267

SPAT

Desensitisation

225.1

307.7

266

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

5.2

307.7

952

1981

R03BA02

ATC

budesonide; inhalant

4.7

307.7

3227

9325

L27.2

ICD-10 Finland

Dermatitis due to ingested food

9.4

307.7

537

595

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

112.9

307.7

416

S01GX01

ATC

cromoglicic acid; ophthalmic

7.4

307.7

5171

12940

R03AC03

ATC

terbutaline; inhalant

4.0

307.7

2264

6782

XQ800

NOMESCO Finland

Prick test

10.1

307.7

2969

4041

V01AA02

ATC

grass pollen; parenteral

79.2

307.7

466

R03BA05

ATC

fluticasone; inhalant

4.3

307.7

3362

10509

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

5.7

307.7

3505

8675

R06AE07

ATC

cetirizine; oral

5.2

307.7

6956

32398

J45.8

ICD-10 Finland

Mixed asthma

7.4

307.7

624

883

R01AD08

ATC

fluticasone; nasal

4.0

307.7

4654

18028

R97

ICPC

Allergic rhinitis

6.9

307.7

723

1114

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

5.6

307.7

836

1592

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.7

305.5

756

1701

J31.0

ICD-10 Finland

Chronic rhinitis

3.3

304.9

1312

4353

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

294.7

1877

7742

R06.2

ICD-10 Finland

Wheezing

4.4

292.8

790

1902

XQ802

NOMESCO Finland

Epicutan test

4.4

286.2

771

1853

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.3

271.6

1127

3645

R03AK08

ATC

formoterol and beclometasone; inhalant

4.7

270.3

658

1458

R06.0

ICD-10 Finland

Dyspnoea

2.4

263.2

2373

11476

D07AA02

ATC

hydrocortisone; topical

2.5

258.7

2075

9511

E000001, ,

ATC

2.3

258.4

2538

12724

R03BB04

ATC

tiotropium bromide; inhalant

4.0

252.8

768

2015

J45.1

ICD-10 Finland

Nonallergic asthma

3.4

251.4

985

3068

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

248.0

930

2816

H02AB04

ATC

methylprednisolone; systemic

2.8

245.1

1453

5733

R03AC12

ATC

salmeterol; inhalant

5.5

244.6

496

938

R03AC13

ATC

formoterol; inhalant

4.7

241.8

595

1328

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

91.5

241.7

128

R06AX12

ATC

terfenadine; oral

4.0

234.7

700

1810

J30.0

ICD-10 Finland

Vasomotor rhinitis

5.6

232.4

455

833

D11AH01

ATC

tacrolimus; topical

8.1

226.9

309

386

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.4

225.1

602

1434

R01AC02

ATC

levocabastine; nasal

4.7

222.9

537

1177

H02AB07

ATC

prednisone; oral

2.8

220.3

1272

4934

S01GX09

ATC

olopatadine; ophthalmic

4.7

220.1

532

1169

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

4.6

219.0

542

1214

E000002, ,

ATC

2.5

217.5

1590

6929

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

206.1

3175

18674

J46

ICD-10 Finland

Status asthmaticus

5.4

199.0

403

760

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.4

196.6

764

2356

D07AB08

ATC

desonide; topical

2.6

196.6

1333

5587

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.5

191.2

1459

6457

J01FA10

ATC

azithromycin; systemic

1.9

188.6

6551

49884

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.4

170.1

288

457

R03BC01

ATC

cromoglicic acid; inhalant

5.6

163.4

317

574

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

7.0

161.9

250

360

J01FA09

ATC

clarithromycin; systemic

1.9

160.1

3213

20270

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

4.3

158.4

427

1020

R05

ICD-10 Finland

Cough

2.0

157.3

2144

11889

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

157.3

2848

17374

DHB50

NOMESCO Finland

Turbinoplasty

4.3

155.4

421

1009

D07AC13

ATC

mometasone; topical

1.9

155.4

2632

15702

S01GX04

ATC

nedocromil; ophthalmic

5.8

153.3

286

499

J33.8

ICD-10 Finland

Other polyp of sinus

6.2

151.1

263

429

R03DA04

ATC

theophylline; systemic, rectal

4.2

149.3

407

980

Z3231

NOMESCO Finland

Registered nurse

1.9

148.2

2559

15322

J34.2

ICD-10 Finland

Deviated nasal septum

3.2

146.3

618

1998

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.0

145.9

438

1132

R06AX18

ATC

acrivastine; oral

4.7

144.6

346

752

L20

ICD-10 Finland

Atopic dermatitis

3.1

142.8

629

2084

R02

ICPC

Shortness of breath/dyspnoea

2.3

134.5

1173

5450

XQ899

NOMESCO Finland

Other assessment of skin

13.7

134.4

126

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

7.9

134.1

186

237

D07AC01

ATC

betamethasone; topical

1.8

132.7

3077

20020

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.4

132.1

488

1451

J01FA06

ATC

roxithromycin; oral

1.7

130.8

3276

21768

J01AA02

ATC

doxycycline; systemic

1.7

128.7

6271

49701

D02AX

ATC

Other emollients and protectives

3.2

128.0

524

1660

R06AX11

ATC

astemizole; oral

3.4

127.8

490

1491

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

125.5

6206

49202

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

124.8

5473

42014

D11AH02

ATC

pimecrolimus; topical

9.4

123.4

148

157

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.1

123.2

543

1797

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.2

121.7

337

820

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

120.9

1383

7132

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.2

119.8

512

1664

R03BC03

ATC

nedocromil; inhalant

2.8

116.3

614

2245

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

115.7

3108

20888

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

114.1

1721

9754

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

7.1

110.4

167

235

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.9

109.2

333

869

E000007, ,

ATC

2.5

105.4

694

2833

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

104.8

1986

12047

A02BC05

ATC

esomeprazole; systemic

1.7

104.7

3109

21322

A02BC02

ATC

pantoprazole; systemic

1.6

96.3

5161

40446

D02AE01

ATC

carbamide; topical

2.5

96.3

667

2785

N05BB01

ATC

hydroxyzine; systemic

2.4

95.2

677

2861

R01AD59

ATC

mometasone, combinations; nasal

2.6

94.5

596

2380

E000006, ,

ATC

2.5

93.9

646

2688

R03AK11

ATC

formoterol and fluticasone; inhalant

3.9

93.0

285

746

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.9

89.4

163

278

S01GX06

ATC

emedastine; ophthalmic

5.2

89.3

186

359

R03CC02

ATC

salbutamol; systemic

1.9

89.1

1299

7230

E000003, ,

ATC

2.7

89.0

498

1873

R03DC01

ATC

zafirlukast; oral

6.1

88.0

153

249

XG405

NOMESCO Finland

Education on PEF monitoring

5.1

87.5

187

369

D11AX14

ATC

[U] tacrolimus

8.0

85.5

116

144

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

84.2

2834

19809

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.7

83.7

273

746

L50.0

ICD-10 Finland

Allergic urticaria

3.0

83.6

373

1240

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

82.3

1936

12369

J20

ICD-10 Finland

Acute bronchitis

2.0

82.1

953

4901

J33.0

ICD-10 Finland

Polyp of nasal cavity

3.6

81.8

272

753

UDM02

NOMESCO Finland

Sinoscopy

3.8

81.7

257

685

395

Kela drug reimbursment

Dupilumab

13.8

80.5

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

6.7

79.3

126

187

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.2

78.1

163

315

D11AH05

ATC

dupilumab; topical

13.4

78.0

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

77.4

839

4205

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

5.1

77.1

165

326

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.0

76.3

354

1203

SPAT1058

SPAT

PEF monitoring instruction

2.2

76.3

680

3159

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

76.2

2234

15047

S01GX05

ATC

lodoxamide; ophthalmic

4.8

76.1

174

364

XG430

NOMESCO Finland

Spiroegometry

8.2

75.6

101

123

L50.8

ICD-10 Finland

Other urticaria

3.5

72.4

254

729

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

4.3

71.2

188

441

M25.5

ICD-10 Finland

Pain in joint

1.5

70.8

2836

20440

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

70.3

3540

26740

G47.3

ICD-10 Finland

Sleep apnoea

1.7

69.6

1549

9707

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

3.2

69.1

288

920

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

10.8

68.3

J37.0

ICD-10 Finland

Chronic laryngitis

3.1

65.6

285

933

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

65.3

2150

14798

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

65.2

1677

10886

M79.6

ICD-10 Finland

Pain in limb

1.5

64.5

3471

26443

J01DA01

ATC

[U] cefalexin

1.4

64.4

5180

42540

XQ801

NOMESCO Finland

Intracutantest

7.1

63.5

135

R74

ICPC

Upper respiratory infection acute

1.4

63.3

3975

31144

J02AC01

ATC

fluconazole; systemic

1.5

63.2

3572

27438

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

4.6

63.1

152

332

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

63.1

1033

5924

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

62.7

459

1958

J01DB01

ATC

cefalexin; oral

1.6

62.2

7584

67280

R01AC07

ATC

nedocromil; nasal

7.5

61.6

116

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

60.8

2512

18107

N02AX02

ATC

tramadol; systemic, rectal

1.5

60.6

2839

20986

R06AE08, ,

ATC

5.0

60.3

129

255

D11AX15

ATC

[U] pimecrolimus

9.1

60.3

R51.80

ICD-10 Finland

Headache

1.6

60.1

1705

11309

M01AE02

ATC

naproxen; oral, rectal

1.4

60.0

5366

44654

A02BC01

ATC

omeprazole; systemic

1.6

59.7

1896

12908

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

4.3

59.5

154

356

J01CA04

ATC

amoxicillin; systemic

1.6

59.1

8176

74029

M03BX02

ATC

tizanidine; oral

1.4

57.3

5170

42928

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

56.7

1791

12162

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

56.5

356

1417

R03BB01

ATC

ipratropium bromide; inhalant

3.7

56.3

179

481

J01FA15

ATC

telithromycin; oral

1.9

56.2

770

4169

ZXC60

NOMESCO Finland

Application of heat

3.9

56.0

167

429

A02BC04

ATC

rabeprazole; oral

1.9

55.9

715

3783

M79.1

ICD-10 Finland

Myalgia

1.6

55.8

1372

8775

R01AC03

ATC

azelastine; nasal

8.2

55.5

XQ830

NOMESCO Finland

Exposure to foodstuff

9.9

54.8

J30.2

ICD-10 Finland

Other seasonal allergic rhinitis

7.1

54.8

117

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

54.3

2866

21576

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.5

54.1

137

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.5

54.0

134

300

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

53.1

463

2127

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

53.0

1623

10923

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

51.9

883

5108

R05

ICPC

Cough

1.5

51.8

2165

15558

G44.2

ICD-10 Finland

Tension-type headache

1.6

51.6

1317

8489

J01FF01

ATC

clindamycin; systemic

1.5

50.5

2011

14298

J01DA06

ATC

[U] cefuroxime

1.7

50.2

1122

6991

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

49.8

1618

11020

A02BC03

ATC

lansoprazole; oral

1.5

49.7

1682

11556

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

49.7

833

4795

J32.4

ICD-10 Finland

Chronic pansinusitis

3.5

49.6

169

476

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

49.4

1119

6994

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

8.8

49.3

XQ820

NOMESCO Finland

Exposure to medicinal substance

6.3

49.3

131

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

48.8

618

3257

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

48.2

1241

8007

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

48.1

1829

12869

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.6

47.9

113

243

49300

ICD-8 Finland

Asthma, bronchiale

3.5

46.9

160

451

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.4

46.6

173

515

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

46.4

1490

10105

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

46.1

129

317

M01AH05

ATC

etoricoxib; oral

1.4

45.9

4837

40544

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.4

45.8

166

487

D07AD01

ATC

clobetasol; topical

1.6

44.9

1157

7456

S87

ICPC

Dermatitis/atopic eczema

2.3

43.9

325

1393

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

43.5

2948

22981

ZX101

NOMESCO Finland

Sublingual

95.3

43.5

J01

ICD-10 Finland

Acute sinusitis

1.9

43.4

605

3288

Z58.8

ICD-10 Finland

Other problems related to physical environment

11.8

43.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

42.9

2420

18283

A07AA02

ATC

nystatin; oral

2.3

42.8

347

1546

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.7

42.5

228

838

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

42.3

2209

16456

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

42.2

3239

25730

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

42.1

798

4750

SPAT1057

SPAT

Peak expiratory flow measurement

2.9

42.1

204

711

J01DC02

ATC

cefuroxime; systemic

2.0

42.0

505

2613

R06.5

ICD-10 Finland

Mouth breathing

1.8

41.9

716

4138

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

41.2

2051

15135

N06AX11

ATC

mirtazapine; oral

1.4

40.8

2600

20017

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

40.6

715

4166

R53

ICD-10 Finland

Malaise and fatigue

1.4

40.4

1992

14667

N03AX16

ATC

[U] pregabalin

1.5

40.1

1446

10024

A02BA02

ATC

ranitidine; systemic

1.6

39.8

953

6024

X58

ICD-10 Finland

Exposure to other specified factors

1.5

39.7

1300

8830

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.9

39.6

116

295

WQ000, ,

SPAT

138.8

39.5

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

4.9

39.4

177

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

39.4

3370

27149

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

39.4

1123

7397

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

39.3

832

5097

R42

ICD-10 Finland

Dizziness and giddiness

1.5

39.0

1403

9713

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

38.8

1411

9789

L01

ICPC

Neck symptom/complaint

1.5

38.7

1368

9438

J01DA09

ATC

[U] cefadroxil

1.4

38.6

2127

15953

ZXA10

NOMESCO Finland

Bilateral

1.5

38.5

1169

7806

K07.60

ICD-10 Finland

Snapping jaw

1.8

38.1

579

3230

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

38.0

176

598

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

37.7

418

2102

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

4.0

37.7

107

266

S01BA01

ATC

dexamethasone; ophthalmic

2.5

37.6

235

933

Z3226

NOMESCO Finland

Physiotherapist

1.5

37.5

1321

9100

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

37.5

279

1198

R01AD

ATC

Corticosteroids

4.2

37.5

233

E000004, ,

ATC

2.6

37.3

212

803

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

4.4

37.1

206

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

36.4

551

3069

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

36.4

1563

11194

N02BE01

ATC

paracetamol; systemic, rectal

1.4

36.3

7430

67598

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

36.1

1444

10200

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

35.8

624

3623

L20.8

ICD-10 Finland

Other atopic dermatitis

3.1

35.6

148

473

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

35.5

863

5467

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

4.7

35.4

170

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

6.0

35.4

102

J01MA12

ATC

levofloxacin; systemic

1.6

34.8

981

6436

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

4.4

34.6

193

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

34.4

1826

13571

R49.08

ICD-10 Finland

Other specified dysphonia

2.8

34.4

178

643

J01MA14

ATC

moxifloxacin; systemic

1.8

34.3

533

2992

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

6.3

33.9

Z01.2

ICD-10 Finland

Dental examination

1.3

33.8

4549

38785

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

4.0

33.5

236

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

33.4

352

1738

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.7

33.3

106

286

J01FA01

ATC

erythromycin; systemic

1.5

33.2

1391

9897

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

32.8

701

4300

WZC30

NOMESCO Finland

Teaching

1.5

32.5

955

6317

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

32.5

1043

7033

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

32.3

2181

16837

R01AX03

ATC

ipratropium bromide; nasal

3.2

32.3

127

393

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

32.3

1083

7372

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.7

32.2

101

270

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

32.0

1901

14373

WX002

NOMESCO Finland

Sedation and analgesia

1.5

31.9

1115

7652

J05AB01

ATC

aciclovir; systemic

1.4

31.7

1632

12043

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

31.6

484

2704

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

31.4

739

4640

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

8.6

31.4

505

Kela drug reimbursment

Allergy to cow's milk in infants

5.9

31.4

M02AA07

ATC

piroxicam; topical

1.4

31.4

1926

14637

M79.7

ICD-10 Finland

Fibromyalgia

2.1

31.2

316

1537

R03BA07

ATC

mometasone; inhalant

3.8

31.2

253

R75

ICPC

Sinusitis acute/chronic

1.8

31.0

462

2561

D07CB01

ATC

triamcinolone and antibiotics; topical

2.9

30.9

145

497

C09CA06

ATC

candesartan; oral

1.4

30.7

1442

10465

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

30.2

422

2293

M54.5

ICD-10 Finland

Low back pain

1.3

30.1

2924

23750

A06AC51

ATC

ispaghula, combinations; oral

2.0

30.0

315

1553

SPAT1325

SPAT

Vaccination

1.3

29.9

2387

18857

H10

ICD-10 Finland

Conjunctivitis

1.6

29.7

770

4949

R29

ICPC

Respiratory symptom/complaint other

1.7

29.7

552

3262

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

29.6

901

6001

L03

ICPC

Low back symptom/complaint

1.3

29.6

2276

17879

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

29.6

454

2539

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

29.3

767

4940

K30

ICD-10 Finland

Functional dyspepsia

1.5

29.2

838

5510

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

29.1

673

4206

N03AX12

ATC

[U] gabapentin; oral

1.5

29.0

996

6803

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

28.9

1611

12029

T78.3

ICD-10 Finland

Angioneurotic oedema

3.1

28.9

123

399

J01AA04

ATC

lymecycline; systemic

1.4

28.9

1324

9560

Z2221

NOMESCO Finland

Medical doctor

1.3

28.8

2152

16822

J02AC02

ATC

itraconazole; systemic

1.5

28.8

1162

8196

SPAT1059

SPAT

Spirometry at the office

2.0

28.7

302

1490

D09AB01

ATC

zinc bandage without supplements; topical

2.9

28.5

131

444

L50.3

ICD-10 Finland

Dermatographic urticaria

2.4

28.4

195

809

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

28.4

831

5487

J04.0

ICD-10 Finland

Acute laryngitis

1.8

28.4

481

2769

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

28.3

748

4825

R21

ICPC

Throat symptom/complaint

1.3

28.3

2701

21846

J05AB11

ATC

valaciclovir; oral

1.5

28.2

1023

7064

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

28.1

967

6608

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

28.0

731

4704

XG432

NOMESCO Finland

Cold exponation and spirometry

7.5

27.9

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.5

27.9

177

708

GD1AA, ,

SPAT

1.5

27.7

1116

7864

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

27.6

334

1731

L17

ICPC

Foot/toe symptom/complaint

1.3

27.6

2127

16690

J01MA02

ATC

ciprofloxacin; systemic

1.3

27.6

2300

18251

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

27.4

1162

8264

UJF32

NOMESCO Finland

Coloscopy

1.4

27.4

1360

9953

EMB10

NOMESCO Finland

Tonsillectomy

1.6

27.3

749

4872

R09

ICPC

Sinus symptom/complaint

1.5

27.3

819

5434

W84

ICD-10 Finland

Unspecified threat to breathing

5.8

27.3

N05BA04

ATC

oxazepam; oral

1.3

27.2

1890

14600

R51

ICD-10 Finland

Headache

1.6

27.1

584

3586

R12

ICD-10 Finland

Heartburn

1.6

27.1

628

3928

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

7.2

27.1

344

Kela drug reimbursment

Omalizumab

7.5

26.7

R07

ICPC

Sneezing/nasal congestion

1.5

26.6

778

5132

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

26.6

224

1015

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

26.6

1239

8962

X57

ICD-10 Finland

Unspecified privation

2.4

26.6

178

731

DM1QA, ,

SPAT

1.8

26.4

406

2271

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

26.4

660

4202

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.3

3087

25593

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

26.3

1773

13625

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

26.2

3759

31933

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

26.2

156

606

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

26.1

1774

13646

SPAT1310

SPAT

Counselling related to known health issue

1.3

26.0

2621

21304

R04

ICPC

Breathing problem other

2.0

25.9

268

1316

M54

ICD-10 Finland

Dorsalgia

1.4

25.7

1083

7690

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

3.2

25.7

101

313

A01AB09

ATC

miconazole; local oral

1.6

25.7

548

3356

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

25.5

767

5089

N06AX21

ATC

duloxetine; oral

1.5

25.4

880

6015

A04

ICPC

Weakness/tiredness general

1.4

25.3

1260

9214

R00.2

ICD-10 Finland

Palpitations

1.6

25.3

655

4205

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.5

25.0

160

644

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

24.9

837

5684

J32

ICD-10 Finland

Chronic sinusitis

3.4

24.9

265

S29

ICPC

Skin symptom/complaint other

1.4

24.9

1375

10232

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

24.9

1541

11678

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.5

24.6

243

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

5.4

24.6

R83

ICPC

Respiratory infection other

1.3

24.5

3001

24962

Z71.8

ICD-10 Finland

Other specified counselling

1.3

24.5

2812

23205

M01AH01

ATC

celecoxib; oral

1.5

24.3

910

6315

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.8

24.1

118

415

A03FA02

ATC

cisapride; oral, rectal

1.8

24.1

391

2223

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.9

24.0

289

1496

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

24.0

2599

21281

M01AB05

ATC

diclofenac; systemic, rectal

1.2

23.9

4866

42865

A12

ICPC

ALLERGY/ALLERGIC REACTION

4.3

23.7

137

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

23.7

3236

27238

D06AX01

ATC

fusidic acid; topical

1.5

23.6

766

5165

L15

ICPC

Knee symptom/complaint

1.3

23.6

1680

12992

N01

ICPC

Headache

1.4

23.5

1495

11365

R4110

NOMESCO Finland

Physiotherapy

1.3

23.5

1775

13845

J01MA06

ATC

norfloxacin; oral

1.5

23.4

725

4841

S01AA01

ATC

chloramphenicol; ophthalmic

1.8

23.3

387

2214

N05CF01

ATC

zopiclone; oral

1.3

23.2

1784

13946

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

23.1

310

1663

L13

ICPC

Hip symptom/complaint

1.4

23.0

920

6463

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.2

22.9

289

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.7

22.8

420

2475

H01

ICPC

Ear pain/earache

1.4

22.8

1223

9048

R06AX25

ATC

mizolastine; oral

5.3

22.6

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.2

22.6

190

862

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

2.5

22.5

141

562

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

22.3

2560

21069

E0001A1, ,

ATC

2.0

22.1

252

1282

C07AA05

ATC

propranolol; systemic

1.3

22.0

1741

13652

WX722

NOMESCO Finland

PEEP

2.0

21.9

227

1115

EMB30

NOMESCO Finland

Adenotomy

1.6

21.8

547

3485

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

21.8

689

4620

J31.1

ICD-10 Finland

Chronic nasopharyngitis

3.1

21.6

284

Z01.7

ICD-10 Finland

Laboratory examination

1.4

21.6

1089

7968

ZXE00

NOMESCO Finland

One hour or less

1.3

21.5

2964

24900

N06AB10

ATC

escitalopram; oral

1.3

21.5

2012

16129

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.9

21.5

332

F29

ICPC

Eye symptom/complaint other

1.5

21.5

746

5098

H92.0

ICD-10 Finland

Otalgia

1.5

21.5

594

3869

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

21.4

460

2823

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.9

21.3

162

N05CF02

ATC

zolpidem; oral

1.4

21.3

1182

8785

R03DX05

ATC

omalizumab; parenteral

7.0

21.2

L12

ICPC

Hand/finger symptom/complaint

1.3

21.1

1376

10486

D06BX01

ATC

metronidazole; topical

1.5

20.8

726

4963

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

20.7

542

3485

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.2

20.7

170

764

L02

ICPC

Back symptom/complaint

1.4

20.7

904

6451

R01AD04

ATC

flunisolide; nasal

4.2

20.7

131

N06AB04

ATC

citalopram; systemic

1.3

20.6

1370

10471

UDC00

NOMESCO Finland

Ear microscopy

1.6

20.5

539

3471

J47

ICD-10 Finland

Bronchiectasis

3.3

20.4

238

R07.0

ICD-10 Finland

Pain in throat

1.5

20.4

730

5016

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.5

20.3

108

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

8.6

20.3

D07XB05

ATC

dexamethasone; topical

2.2

20.3

178

822

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

20.1

1506

11706

OAA65, ,

SPAT

1.3

20.0

1850

14792

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

19.9

590

3901

AA40B, ,

NOMESCO Finland

5.4

19.8

J01AA07

ATC

tetracycline; systemic

1.3

19.8

1306

9960

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

19.8

375

2226

L16

ICPC

Ankle symptom/complaint

1.4

19.8

995

7271

M02AA10

ATC

ketoprofen; topical

1.4

19.7

842

5983

S01AD03

ATC

aciclovir; ophthalmic

2.0

19.5

212

1060

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.3

19.5

153

675

R01BA01

ATC

phenylpropanolamine; oral

1.7

19.5

336

1944

D82

ICPC

Teeth/gum disease

1.2

19.5

3575

30898

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

19.4

170

785

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

19.4

460

2892

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

19.4

1808

14463

G43

ICD-10 Finland

Migraine

1.5

19.3

654

4446

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

19.3

6902

63817

K08.80

ICD-10 Finland

Toothache NOS

1.4

19.3

782

5504

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

19.2

300

1687

J33.9

ICD-10 Finland

Nasal polyp, unspecified

2.9

19.2

315

N02CC04

ATC

rizatriptan; oral

1.5

19.0

520

3378

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

18.9

3392

29217

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

18.8

889

6430

G43.3

ICD-10 Finland

Complicated migraine

2.0

18.7

198

982

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

18.7

4111

36134

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

18.7

672

4622

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

18.6

1226

9345

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.7

18.6

102

382

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

18.5

955

7008

A98

ICPC

Health maint/preventive medicine

2.0

18.5

9353

90681

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

18.5

1203

9154

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

18.4

906

6593

D07AB01

ATC

clobetasone; topical

2.0

18.4

213

1090

R52.9

ICD-10 Finland

Pain, unspecified

1.5

18.4

684

4735

M03AX01

ATC

botulinum toxin; parenteral

2.2

18.4

149

667

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.6

18.3

430

2697

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

18.3

1385

10767

N06AX12

ATC

bupropion; oral

1.4

18.2

768

5442

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

18.2

840

6048

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

18.1

624

4254

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.6

18.0

L08

ICPC

Shoulder symptom/complaint

1.3

18.0

1312

10144

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

18.0

1272

9792

DPA30

NOMESCO Finland

Sphenotomy

3.6

18.0

159

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

3.8

17.9

141

DHB40

NOMESCO Finland

Conchotomy

7.3

17.9

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

17.9

461

2954

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

17.8

867

6296

B37.0

ICD-10 Finland

Candidal stomatitis

2.8

17.8

301

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

17.8

350

2101

J01DA08

ATC

[U] cefaclor

1.3

17.7

1387

10826

SPAT1283

SPAT

Restricted health certificate

1.2

17.6

2281

18943

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

17.5

357

2161

H02

ICPC

Hearing complaint

1.5

17.5

537

3578

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

3.5

17.4

167

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.8

17.4

135

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

17.4

329

1953

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

17.4

540

3604

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

17.4

328

1946

N06BA04

ATC

methylphenidate; oral

1.5

17.3

520

3447

P06

ICPC

Sleep disturbance

1.4

17.3

1005

7511

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

17.3

2515

21150

J33

ICD-10 Finland

Nasal polyp

3.4

17.2

173

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

17.2

284

1624

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

17.1

2295

19127

K07.61

ICD-10 Finland

Cracking jaw joint

1.9

17.1

223

1188

XG488

NOMESCO Finland

Other provokation of respiratroy tract

7.3

17.1

C05AA08

ATC

fluocortolone; rectal, topical

1.4

17.1

709

5009

A99

ICPC

Disease/condition unspecnature/site

1.5

17.0

583

3971

N05BA12

ATC

alprazolam; oral

1.5

17.0

592

4045

M01AX17

ATC

nimesulide; oral

1.4

17.0

1018

7644

ZX112

NOMESCO Finland

Subcutaneous

2.3

17.0

132

581

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

17.0

387

2410

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

17.0

583

3974

N02BF02

ATC

pregabalin; oral

1.6

16.9

383

2381

D01

ICPC

Abdominal pain/cramps general

1.3

16.9

1141

8719

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

16.9

1302

10139

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

16.9

348

2114

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

16.9

509

3378

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

6.3

16.8

S18

ICPC

Laceration/cut

1.2

16.8

2912

24922

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

16.7

567

3857

R52.2

ICD-10 Finland

Other chronic pain

1.8

16.7

244

1348

N06AA09

ATC

amitriptyline; systemic

1.6

16.6

428

2743

R13

ICD-10 Finland

Dysphagia

1.6

16.6

343

2084

S88

ICPC

Dermatitis contact/allergic

2.0

16.6

175

867

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

16.6

555

3761

C08DA01

ATC

verapamil; systemic

2.0

16.5

179

896

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.5

16.5

105

423

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.0

16.4

114

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

16.4

483

3188

F03

ICPC

Eye discharge

1.5

16.4

564

3844

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

16.3

641

4483

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

16.3

894

6622

N06AX26

ATC

vortioxetine; oral

1.4

16.2

709

5056

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.1

16.2

160

775

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

16.1

6796

63132

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.3

16.1

115

489

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

16.0

639

4481

XG431

NOMESCO Finland

Oscillometric spirometry with exercise provocation

4.5

16.0

N06AB06

ATC

sertraline; oral

1.3

16.0

1030

7817

F32

ICD-10 Finland

Depressive episode

1.5

15.9

546

3719

R49.01

ICD-10 Finland

Functional dysphonia

1.9

15.9

191

991

SPAT1211

SPAT

Application of soft bandage

1.4

15.9

643

4522

50708

ICD-8 Finland

Hay fever, Alia definita

4.9

15.9

OAB42, ,

SPAT

1.4

15.8

919

6866

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

15.8

471

3118

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.9

15.8

199

1049

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.1

15.8

156

756

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

15.8

840

6191

C07AB07

ATC

bisoprolol; oral

1.2

15.7

2058

17084

XQ817, ,

NOMESCO Finland

12.0

15.7

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

15.7

715

5136

A02BA04

ATC

nizatidine; systemic

1.7

15.6

279

1632

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.7

15.6

301

SDA03

NOMESCO Finland

Periodontal treatment

1.2

15.6

3372

29427

R35

ICD-10 Finland

Polyuria

1.7

15.6

294

1746

4222

FHL

Endonasal etmoidectomy

4.3

15.6

OAB93, ,

SPAT

1.4

15.5

597

4159

ZXD20

NOMESCO Finland

Day surgery

1.4

15.4

826

6092

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

15.4

326

1994

J35.1

ICD-10 Finland

Hypertrophy of tonsils

1.7

15.4

261

1505

SPAT1312

SPAT

General health counselling

1.2

15.4

2880

24783

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

15.3

528

3600

F71

ICPC

Conjunctivitis allergic

4.0

15.3

103

WIX00

NOMESCO Finland

Allergy cleanup guidance

6.1

15.2

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

15.2

574

3986

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

15.1

2317

19541

SPAT1324

SPAT

Screening procedure

0.8

15.1

995

12574

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

15.0

1198

9360

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

15.0

370

2348

TQC05

NOMESCO Finland

Puncture of skin of upper limb

6.6

15.0

R50.9

ICD-10 Finland

Fever, unspecified

1.3

15.0

1133

8790

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

2.9

15.0

236

A01

ICPC

Pain general/multiple sites

1.4

15.0

566

3929

R07.3

ICD-10 Finland

Other chest pain

1.4

15.0

581

4054

A03

ICPC

Fever

1.2

14.9

1845

15210

H01.0

ICD-10 Finland

Blepharitis

1.5

14.8

533

3665

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

14.8

1713

14011

R03BB07

ATC

umeclidinium bromide; inhalant

3.6

14.8

128

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

14.7

468

3141

Z05

ICPC

Work problem

1.6

14.7

308

1880

A07DA03

ATC

loperamide; oral

2.1

14.7

133

624

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

14.7

330

2050

SPAT1260

SPAT

Consultation of another employee

1.3

14.6

1188

9305

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

14.6

239

1365

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

14.6

3814

33792

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

14.6

476

3211

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

14.6

1324

10520

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

14.4

764

5625

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

14.4

2732

23508

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

14.4

221

1240

A01AB04

ATC

amphotericin B; local oral

1.9

14.3

170

880

R06

ICD-10 Finland

Abnormalities of breathing

2.5

14.3

344

WQ007, ,

NOMESCO Finland

6.2

14.3

M24.2

ICD-10 Finland

Disorder of ligament

2.2

14.3

118

534

SPAT1254

SPAT

Administration of medicine

1.3

14.3

1079

8369

M35.7

ICD-10 Finland

Hypermobility syndrome

2.0

14.3

159

805

M54.1

ICD-10 Finland

Radiculopathy

1.8

14.2

227

1289

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

14.2

2612

22406

H29

ICPC

Ear symptom/complaint other

1.4

14.2

683

4951

N06AX16

ATC

venlafaxine; oral

1.3

14.1

1184

9308

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

14.1

551

3850

L50.2

ICD-10 Finland

Urticaria due to cold and heat

3.6

14.1

123

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

3.6

14.1

123

SBB10

NOMESCO Finland

Dental impressions

1.3

14.1

852

6403

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

14.1

174

913

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

14.0

459

3102

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

13.9

345

2193

R51.81

ICD-10 Finland

Facial pain NOS

1.9

13.9

169

881

P01AB01

ATC

metronidazole; oral, rectal

1.2

13.9

2901

25165

D11

ICPC

Diarrhoea

1.3

13.9

1124

8796

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

13.9

657

4748

SPAT1263

SPAT

Sampling

1.2

13.8

3395

29874

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

13.8

179

954

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

13.8

621

4450

S21

ICPC

Skin texture symptom/complaint

1.3

13.8

904

6873

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

13.8

442

2973

J01MA01

ATC

ofloxacin; systemic

1.6

13.7

339

2154

J32.8

ICD-10 Finland

Other chronic sinusitis

3.7

13.7

116

XG405, ,

SPAT

2.5

13.7

316

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

13.7

5406

49500

N06AB03

ATC

fluoxetine; oral

1.3

13.6

872

6605

D06BB03

ATC

aciclovir; topical

1.6

13.6

288

1764

XG466

NOMESCO Finland

Sleep oxymetry

2.0

13.6

141

697

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

5.5

13.6

N02CC06

ATC

eletriptan; oral

1.6

13.5

338

2153

N02CC07

ATC

frovatriptan; oral

1.5

13.5

397

2621

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

13.5

499

3449

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.9

13.5

159

822

N17

ICPC

Vertigo/dizziness

1.4

13.4

692

5072

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

13.4

511

3554

A97

ICPC

No disease

1.3

13.3

1396

11279

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

13.2

597

4279

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

13.2

141

704

R49.0

ICD-10 Finland

Dysphonia

2.0

13.2

136

671

WZB00, ,

SPAT

1.3

13.1

1050

8201

D10AX03

ATC

azelaic acid; topical

1.3

13.1

842

6380

R11

ICD-10 Finland

Nausea and vomiting

1.4

13.1

668

4886

S06.0

ICD-10 Finland

Concussion

1.3

13.1

836

6331

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

1.7

12.9

228

1331

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

12.9

120

569

N02BF01

ATC

gabapentin; oral

1.5

12.9

463

3184

R05DA01

ATC

ethylmorphine; oral

1.5

12.8

422

2852

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

12.8

237

1402

L11

ICPC

Wrist symptom/complaint

1.3

12.8

776

5832

J32.1

ICD-10 Finland

Chronic frontal sinusitis

3.2

12.8

151

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

12.8

613

4441

SPAT1104

SPAT

Monitoring of emergency patient

1.5

12.7

346

2248

D01AA02

ATC

natamycin; topical

2.0

12.7

137

687

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.6

12.7

321

2053

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

4.2

12.6

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

12.6

2026

17121

M01AH02

ATC

rofecoxib; oral

1.4

12.6

469

3248

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.7

12.6

254

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

12.6

291

1822

N03AX09

ATC

lamotrigine; oral

1.4

12.5

465

3219

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

12.5

141

718

R04.0

ICD-10 Finland

Epistaxis

1.6

12.5

307

1951

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

12.4

602

4366

N03AX11

ATC

topiramate; oral

1.7

12.4

226

1331

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.3

12.4

1074

8474

OAA51, ,

SPAT

2.5

12.4

285

H03AA01

ATC

levothyroxine sodium; systemic

1.2

12.4

1449

11848

M54.8

ICD-10 Finland

Other dorsalgia

1.6

12.3

313

2002

D06

ICPC

Abdominal pain localized other

1.4

12.3

700

5208

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

12.3

545

3894

D07XC01

ATC

betamethasone; topical

1.4

12.3

637

4671

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

12.2

635

4658

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

12.2

587

4252

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

12.2

734

5510

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.4

12.2

329

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

12.1

619

4528

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

2.0

12.1

134

678

N39.3

ICD-10 Finland

Stress incontinence

1.5

12.1

375

2506

E66.8

ICD-10 Finland

Other obesity

1.5

12.1

430

2953

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

12.1

768

5811

SPAT1153

SPAT

Removal of sutures

1.2

12.0

1693

14118

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.9

11.9

138

709

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

11.9

419

2870

H93.1

ICD-10 Finland

Tinnitus

1.5

11.9

380

2555

J01EA01

ATC

trimethoprim; systemic

1.2

11.9

1715

14328

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

11.9

905

7022

B00.11

ICD-10 Finland

Herpes simplex labialis

1.9

11.9

147

773

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

11.8

457

3188

L10

ICPC

Elbow symptom/complaint

1.5

11.8

393

2664

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

11.8

2920

25624

L60.0

ICD-10 Finland

Ingrowing nail

1.5

11.8

351

2326

N89

ICPC

Migraine

1.4

11.8

445

3092

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

11.7

105

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.4

11.7

449

3127

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.6

11.7

260

1613

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

11.7

491

3476

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

11.7

161

876

J01DC04

ATC

cefaclor; oral

2.0

11.7

125

626

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

11.6

443

3082

L01

ICD-10 Finland

Impetigo

1.8

11.6

162

885

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

11.6

592

4332

SPAT1281

SPAT

Other administrative function

1.4

11.6

553

4003

L04

ICPC

Chest symptom/complaint

1.5

11.5

411

2823

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.9

11.5

134

690

CS494

NOMESCO Finland

Other visual field testing

2.0

11.5

114

555

L23

ICD-10 Finland

Allergic contact dermatitis

2.7

11.5

215

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.1

11.5

101

470

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

11.5

619

4569

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

11.4

105

497

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.0

11.4

167

Z00.0

ICD-10 Finland

General medical examination

1.2

11.4

1401

11509

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

11.3

140

736

SPAT1268

SPAT

Allergy testing

3.6

11.3

103

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

11.3

336

2226

UJD02

NOMESCO Finland

Gastroscopy

1.7

11.3

211

1253

SPAT1229

SPAT

Assessment of need for aid

1.6

11.3

269

1697

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.9

11.3

136

709

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

11.3

1107

8863

R55

ICD-10 Finland

Syncope and collapse

1.4

11.3

512

3675

K58

ICD-10 Finland

Irritable bowel syndrome

1.6

11.3

229

1390

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

11.2

1135

9118

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

11.2

330

2182

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

1.8

11.2

178

1011

D10AF01

ATC

clindamycin; topical

1.5

11.2

367

2482

N05AH04

ATC

quetiapine; oral

1.2

11.1

1490

12350

W19

ICD-10 Finland

Unspecified fall

1.4

11.1

602

4449

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

11.1

411

2847

F02

ICPC

Red eye

1.5

11.1

324

2141

R60.0

ICD-10 Finland

Localized oedema

1.4

11.0

529

3831

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.3

11.0

344

F17

ICPC

Glasses symptom/complaint

2.7

11.0

215

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

10.9

129

668

A07EB01

ATC

cromoglicic acid; oral

11.0

10.9

G50.1

ICD-10 Finland

Atypical facial pain

2.0

10.9

111

546

-1, ,

ICD-10 Finland

1.4

10.9

465

3303

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.5

10.9

256

N04BC05

ATC

pramipexole; oral

1.5

10.9

315

2077

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.7

10.8

173

985

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.1

10.8

430

H00.00

ICD-10 Finland

Hordeolum

1.5

10.8

345

2323

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

1.8

10.7

154

849

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

10.7

111

550

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

10.7

583

4310

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

10.7

423

2965

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

10.7

731

5589

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

10.7

533

3888

WX320

NOMESCO Finland

Spinalanesthesy

1.2

10.7

1264

10338

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

10.6

1498

12471

R06.4

ICD-10 Finland

Hyperventilation

1.9

10.6

130

682

H60

ICD-10 Finland

Otitis externa

1.4

10.6

410

2864

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.5

323

2155

B02AA02

ATC

tranexamic acid; systemic

1.3

10.5

1044

8367

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

10.5

370

2539

M22.4

ICD-10 Finland

Chondromalacia patellae

1.6

10.5

247

1556

XF402

NOMESCO Finland

ECG with work load test

1.5

10.5

378

2605

N76.0

ICD-10 Finland

Acute vaginitis

1.3

10.4

711

5433

D19

ICPC

Teeth/gum symptom/complaint

1.2

10.3

2479

21650

R05CB01

ATC

acetylcysteine; inhalant, oral

3.0

10.3

145

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.9

10.3

128

675

N02CC05

ATC

almotriptan; oral

1.5

10.3

350

2384

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.3

274

1774

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.0

10.3

140

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

10.3

453

3235

L28

ICPC

Limited function/disability (L)

1.3

10.3

680

5173

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.8

10.3

146

803

K80

ICPC

Cardiac arrhythmia NOS

1.4

10.3

383

2656

L57.0

ICD-10 Finland

Actinic keratosis

1.6

10.2

235

1472

SAA04

NOMESCO Finland

Special examination of mouth

1.4

10.2

484

3500

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

10.2

717

5502

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.2

532

3908

XG404, ,

SPAT

3.1

10.2

136

XG413

NOMESCO Finland

Spirometry with oscillometry

3.1

10.1

131

R4190

NOMESCO Finland

Nutritional therapy

1.5

10.1

331

2238

L71.9

ICD-10 Finland

Rosacea, unspecified

1.8

10.1

156

880

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.8

10.1

159

902

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

10.1

2028

17448

N30.2

ICD-10 Finland

Other chronic cystitis

2.8

10.1

174

4224

FHL

Endonasal anthrostomy

2.4

10.1

260

K90.0

ICD-10 Finland

Coeliac disease

1.6

10.0

203

1232

H57.1

ICD-10 Finland

Ocular pain

1.5

10.0

283

1856

AA1AD

NOMESCO Finland

CT of head and brain

1.2

10.0

1174

9584

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

10.0

111

564

M01AC06

ATC

meloxicam; systemic, rectal

1.2

10.0

1968

16898

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

10.0

242

1536

L26

ICD-10 Finland

Exfoliative dermatitis

8.3

9.9

J11

ICD-10 Finland

Influenza, virus not identified

1.9

9.9

120

628

N06AA10

ATC

nortriptyline; systemic

1.9

9.8

125

665

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

2.2

9.8

375

R50

ICPC

Respiratory, Medication/prescr/renewal

4.4

9.8

M54.2

ICD-10 Finland

Cervicalgia

1.4

9.8

520

3830

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

1.8

9.8

154

874

ACC51

NOMESCO Finland

Release of median nerve

1.4

9.8

396

2789

N06BA12

ATC

lisdexamfetamine; oral

1.8

9.8

139

766

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.7

9.7

175

1031

A02BX02

ATC

sucralfate; oral

1.8

9.7

133

724

N62

ICD-10 Finland

Hypertrophy of breast

1.5

9.7

287

1902

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

1.9

9.7

122

647

L86

ICPC

Back syndrome with radiating pain

1.5

9.7

331

2259

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

9.7

111

571

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.3

9.6

296

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.6

9.6

198

1208

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.3

9.6

657

5027

ZY010

NOMESCO Finland

Hospital outpatient

1.4

9.5

518

3829

M75

ICD-10 Finland

Shoulder lesions

1.5

9.5

256

1662

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

9.5

127

686

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.6

9.5

187

1128

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

9.5

581

4372

SPAT1360

SPAT

Extensive global examination

1.4

9.5

368

2571

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

7.7

9.5

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.7

9.5

180

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

9.4

344

2376

N02CC02

ATC

naratriptan; oral

1.8

9.4

138

767

J31.2

ICD-10 Finland

Chronic pharyngitis

2.4

9.4

250

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

1.7

9.4

175

1040

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

9.4

326

2230

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.1

9.4

414

R03DX09

ATC

mepolizumab; parenteral

9.9

9.4

K11.2

ICD-10 Finland

Sialoadenitis

1.6

9.4

201

1238

H60.8

ICD-10 Finland

Other otitis externa

1.6

9.4

209

1300

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.0

9.4

441

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

9.4

416

2976

J02AB02

ATC

ketoconazole; oral

1.7

9.4

166

974

D84.18

ICD-10 Finland

Other specified defect in the complement system

4.9

9.4

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.9

9.3

120

642

J01DB05

ATC

cefadroxil; oral

1.5

9.3

283

1888

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

9.3

263

1728

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

9.3

199

1227

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

9.3

2626

23199

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

9.3

1391

11643

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.9

9.3

108

559

S12

ICPC

Insect bite/sting

1.4

9.2

397

2825

R78

ICPC

Acute bronchitis/bronchiolitis

1.9

9.2

119

636

S01XA18

ATC

ciclosporin; ophthalmic

2.7

9.2

177

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

3.3

9.2

103

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

9.2

4535

41658

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

9.4

9.2

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

3.0

9.1

124

WW200, ,

SPAT

1.2

9.1

1370

11471

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

9.1

2295

20094

T82

ICPC

Obesity

1.5

9.1

311

2125

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

9.0

291

1963

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

9.0

533

3991

S82

ICPC

Naevus/mole

1.2

9.0

950

7664

134

Kela drug reimbursment

General erythroderma

3.8

9.0

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

9.0

191

1175

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.4

9.0

325

2242

S76

ICPC

Skin infection other

1.5

9.0

281

1885

K59.0

ICD-10 Finland

Constipation

1.5

9.0

294

1991

J05AH02

ATC

oseltamivir; oral

2.4

9.0

232

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.2

9.0

331

J06.80

ICD-10 Finland

Continuously repeating infections of a child

3.3

8.9

100

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

4.2

8.9

297, ,

Kela drug reimbursment

9.9

8.9

V01AA11

ATC

animals

9.9

8.9

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.6

8.9

175

1056

WX110

NOMESCO Finland

Infiltration anesthesia

1.1

8.9

6449

60719

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

8.9

208

1310

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

8.9

403

2895

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

8.8

690

5369

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

8.8

1963

17009

50709

ICD-8 Finland

Hay fever, Unspecified

3.2

8.8

101

U07

ICPC

Urine symptom/complaint other

1.4

8.8

363

2567

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

8.8

337

2352

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.7

8.8

140

799

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.4

8.8

315

2172

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.8

8.7

133

749

NA1BG, ,

SPAT

1.8

8.7

132

743

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.5

8.7

269

1802

A08

ICPC

Swelling

1.6

8.7

192

1194

J38.4

ICD-10 Finland

Oedema of larynx

3.1

8.7

107

EB1SA, ,

SPAT

1.4

8.7

452

3323

S06

ICPC

Rash localized

1.4

8.6

334

2334

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

8.6

6133

57599

P03

ICPC

Feeling depressed

1.2

8.6

1131

9341

XF404

NOMESCO Finland

Ambulatory ECG

1.4

8.6

378

2702

H65

ICD-10 Finland

Nonsuppurative otitis media

1.9

8.6

511

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

8.6

1362

11456

N05BA01

ATC

diazepam; systemic, rectal

1.3

8.6

695

5435

N94.1

ICD-10 Finland

Dyspareunia

1.7

8.6

160

954

F33

ICD-10 Finland

Recurrent depressive disorder

1.5

8.5

228

1480

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

8.5

161

962

A01AB10

ATC

natamycin; local oral

1.6

8.5

216

1386

M01AX05

ATC

glucosamine; oral

1.3

8.5

516

3879

K20

ICD-10 Finland

Oesophagitis

2.1

8.5

384

XF640, ,

NOMESCO Finland

2.0

8.5

424

S80.0

ICD-10 Finland

Contusion of knee

1.3

8.5

564

4297

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

8.1

8.5

N03AE01

ATC

clonazepam; systemic

1.5

8.5

292

1998

L20

ICPC

Joint symptom/complaint NOS

1.5

8.5

232

1515

L50.1

ICD-10 Finland

Idiopathic urticaria

2.2

8.5

288

G54.0

ICD-10 Finland

Brachial plexus disorders

1.6

8.5

200

1264

Z2445

NOMESCO Finland

Psychologist

1.4

8.5

420

3064

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

8.4

3133

28179

Z00.8

ICD-10 Finland

Other general examinations

1.3

8.4

568

4334

DM1AI, ,

SPAT

2.1

8.4

333

3028

Kela drug reimbursment

Mepolizumab

8.8

8.4

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

8.4

247

1637

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

8.4

2146

18787

E000008, ,

ATC

3.1

8.4

104

D73

ICPC

Gastroenteritis presumed infection

1.4

8.4

374

2681

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.4

8.4

357

2539

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

8.4

212

1361

P01

ICPC

Feeling anxious/nervous/tense

1.2

8.4

1569

13395

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.4

8.4

339

2390

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

2.5

8.4

198

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

8.4

671

5241

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

8.3

721

5685

E66

ICD-10 Finland

Obesity

1.4

8.3

393

2844

M75.8

ICD-10 Finland

Other shoulder lesions

1.5

8.3

247

1641

N06BA09

ATC

atomoxetine; oral

2.3

8.3

259

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

2.3

8.3

241

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

2.3

8.3

241

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.4

8.3

223

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.4

8.3

441

3254

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

8.3

254

1700

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.9

8.2

484

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.3

8.2

641

4988

G04BD12

ATC

mirabegron; oral

1.4

8.2

372

2674

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

2.5

8.2

206

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

8.2

511

3860

B00.10

ICD-10 Finland

Herpes simplex facialis

2.1

8.2

331

L30

ICD-10 Finland

Other dermatitis

1.6

8.2

171

1050

K04

ICPC

Palpitations/awareness of heart

1.4

8.1

313

2186

S02CA02

ATC

flumetasone and antiinfectives; otic

1.5

8.1

270

1834

K62.6

ICD-10 Finland

Ulcer of anus and rectum

2.2

8.1

312

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

8.1

1823

15793

L71.8

ICD-10 Finland

Other rosacea

1.9

8.1

103

549

J03.8

ICD-10 Finland

Acute tonsillitis due to other specified organisms

2.5

8.1

195

M48.0

ICD-10 Finland

Spinal stenosis

1.4

8.1

339

2404

N06AB05

ATC

paroxetine; oral

1.4

8.1

376

2714

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

1.6

8.1

176

1091

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

8.1

396

2884

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

8.1

472

3532

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

3.8

8.1

S01

ICPC

Pain/tenderness of skin

1.5

8.0

269

1831

R03

ICPC

Wheezing

2.1

8.0

327

D72.1

ICD-10 Finland

Eosinophilia

3.1

8.0

102

N06AG02

ATC

moclobemide; oral

1.6

8.0

197

1257

H65.2

ICD-10 Finland

Chronic serous otitis media

1.9

8.0

103

552

M77.4

ICD-10 Finland

Metatarsalgia

1.4

8.0

393

2863

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.4

8.0

320

2253

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.5

8.0

197

V01AA03

ATC

house dust mites; parenteral

21.7

8.0

OAB44, ,

SPAT

1.3

7.9

779

6234

RL210, ,

NOMESCO Finland

3.5

7.9

ZXA05

NOMESCO Finland

Left side

1.2

7.9

1107

9196

RD210, ,

NOMESCO Finland

1.6

7.9

167

1028

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

7.9

274

1878

S70.0

ICD-10 Finland

Contusion of hip

1.6

7.9

168

1036

D02

ICPC

Abdominal pain epigastric

1.4

7.9

420

3098

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

2.8

7.9

135

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

7.9

344

2458

Z73.0

ICD-10 Finland

Burn-out

1.4

7.9

355

2551

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

7.9

407

2990

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.4

7.8

334

2376

G44.0

ICD-10 Finland

Cluster headache syndrome

1.9

7.8

444

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

1.6

7.8

152

916

SCA02

NOMESCO Finland

Preventive oral health care

1.2

7.8

1198

10038

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.8

571

4406

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

2.7

7.8

141

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

7.8

226

1494

EB1AA, ,

SPAT

1.3

7.8

456

3411

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.4

7.8

217

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

7.8

577

4461

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.8

7.8

125

M01AC01

ATC

piroxicam; systemic, rectal

1.3

7.8

499

3784

L29.9

ICD-10 Finland

Pruritus, unspecified

1.6

7.8

161

987

S03

ICPC

Warts

1.6

7.7

164

1011

M01AB55

ATC

diclofenac, combinations; oral

1.5

7.7

216

1418

K03.80

ICD-10 Finland

Irradiated enamel

1.4

7.7

413

3049

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.3

7.7

452

3384

G43.8

ICD-10 Finland

Other migraine

1.7

7.7

146

875

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.6

7.7

165

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

7.7

310

2185

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

7.7

379

2763

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.5

7.7

266

1823

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

7.7

250

1693

J03

ICD-10 Finland

Acute tonsillitis

1.4

7.7

317

2244

R4110, ,

SPAT

1.4

7.7

408

3010

K03.66

ICD-10 Finland

Tooth plaque

1.3

7.7

579

4488

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

2.5

7.7

177

R03CC03

ATC

terbutaline; systemic

1.4

7.7

292

2038

3DX05, ,

NOMESCO Finland

14.8

7.6

S01AA13

ATC

fusidic acid; ophthalmic

1.5

7.6

248

1679

SPAT1322

SPAT

Pre-employment physical examination

1.6

7.6

151

915

R03DA05

ATC

aminophylline; systemic, rectal

3.4

7.6

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.6

410

3030

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

2.3

7.6

244

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

1.6

7.6

165

1023

SAB03

NOMESCO Finland

Oral health check

1.3

7.6

720

5741

N30

ICD-10 Finland

Cystitis

1.3

7.6

602

4699

C03AA03

ATC

hydrochlorothiazide; oral

1.5

7.6

236

1586

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

7.6

324

2309

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.6

7.5

163

1010

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.2

7.5

857

6972

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.5

927

7604

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

7.5

178

1127

Z2446

NOMESCO Finland

Social worker

1.3

7.5

531

4081

R4190, ,

SPAT

3.5

7.5

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.9

7.5

507

A69.2

ICD-10 Finland

Lyme disease

1.4

7.5

292

2046

N02CX04, ,

ATC

1.9

7.5

417

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

7.5

596

4654

R68

ICD-10 Finland

Other general symptoms and signs

2.2

7.4

272

G04CB01

ATC

finasteride; oral

1.6

7.4

161

998

H10.8

ICD-10 Finland

Other conjunctivitis

2.0

7.4

391

J02

ICD-10 Finland

Acute pharyngitis

1.3

7.4

433

3240

EMB20

NOMESCO Finland

Adenotonsillectomy

1.5

7.4

202

1320

J01.4

ICD-10 Finland

Acute pansinusitis

2.2

7.4

279

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

7.4

241

1635

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.9

7.3

1942

21489

N06AX05

ATC

trazodone; oral

1.6

7.3

165

1032

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

7.3

1487

12767

D01AC03

ATC

econazole; topical

1.5

7.3

241

1637

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

7.3

523

4027

G01AF05

ATC

econazole; vaginal

1.3

7.3

453

3420

M15

ICD-10 Finland

Polyarthrosis

1.6

7.3

159

988

N05AF01

ATC

flupentixol; systemic

2.1

7.3

307

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

7.3

504

3864

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.8

7.3

G01AA10

ATC

clindamycin; vaginal

1.2

7.3

1022

8495

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.4

7.3

323

2317

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

2.6

7.3

147

GX1C5, ,

SPAT

2.9

7.2

114

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

10.7

7.2

K60.1

ICD-10 Finland

Chronic anal fissure

1.6

7.2

142

861

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

7.2

380

2803

L29

ICPC

Musculoskeletal sympt/complt other

1.3

7.1

505

3882

R5110, ,

SPAT

1.5

7.1

227

1532

K03.00

ICD-10 Finland

Approximal wear

1.3

7.1

507

3901

N06AX22

ATC

agomelatine; oral

1.5

7.1

197

1292

49099

ICD-8 Finland

Bronchitis, unspecified

2.3

7.1

214

WX400

NOMESCO Finland

Inhalation anesthesy

1.4

7.1

323

2325

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

1.6

7.1

149

917

K03.08

ICD-10 Finland

Other wear and tear of the teeth

1.6

7.1

175

1119

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.5

7.1

246

1688

S01BA04

ATC

prednisolone; ophthalmic

1.9

7.1

446

A29

ICPC

General symptom/complaint other

1.3

7.1

673

5366

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

1.9

7.1

460

SFA10

NOMESCO Finland

One-surface restoration

1.1

7.1

4917

45818

D84.19

ICD-10 Finland

Unspecified defect in the complement system

19.8

7.1

U02

ICPC

Urinary frequency/urgency

1.2

7.1

879

7217

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

2.9

7.1

110

NH1BG, ,

SPAT

1.6

7.1

142

865

M23.8

ICD-10 Finland

Other internal derangements of knee

1.4

7.1

247

1698

4211

FHL

Transeptal septal resection and reconstruction

2.8

7.1

121

D01AC02

ATC

miconazole; topical

1.4

7.1

322

2320

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

7.0

283

1995

D03

ICPC

Heartburn

1.5

7.0

226

1528

N07CA01

ATC

betahistine; oral

1.4

7.0

261

1814

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

7.0

648

5150

G04CA02

ATC

tamsulosin; oral

1.3

7.0

491

3771

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

7.0

174

1115

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

6.9

183

1188

DGW00

NOMESCO Finland

Dilatation of eustachian tube

3.2

6.9

R25.2

ICD-10 Finland

Cramp and spasm

1.6

6.9

136

824

R30.0

ICD-10 Finland

Dysuria

1.4

6.9

280

1977

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.4

6.9

348

2548

SPAT1139

SPAT

Nutrition survey

1.6

6.9

171

1095

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.4

6.9

304

2178

G01AF04

ATC

miconazole; vaginal

1.4

6.9

265

1854

WZA10

NOMESCO Finland

Extensive medical or dental certificate

1.8

6.9

486

E34.35

ICD-10 Finland

Abnormal growth retardation

2.1

6.9

314

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.3

6.9

381

2831

RF211, ,

NOMESCO Finland

3.6

6.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

6.9

826

6761

N02CD03

ATC

fremanezumab; systemic

1.8

6.8

473

G04CA01

ATC

alfuzosin; oral

1.4

6.8

290

2065

A07EA06

ATC

budesonide; oral, local oral

1.4

6.8

245

1693

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.6

6.8

166

1059

S01GA51

ATC

naphazoline, combinations; ophthalmic

5.4

6.8

SPAT1043

SPAT

Audiometry

1.3

6.8

396

2964

XG460

NOMESCO Finland

Short time oxymetry

2.1

6.8

263

C07AB02

ATC

metoprolol; systemic

1.3

6.8

637

5073

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

6.8

538

4201

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.3

6.8

213

M01AX01

ATC

nabumetone; oral

1.6

6.7

148

922

P76

ICPC

Depressive disorder

1.3

6.7

626

4982

DAX08

NOMESCO Finland

Fitting of hearing aid

1.7

6.7

124

740

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

6.7

907

7510

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.5

6.7

206

1382

WX234

NOMESCO Finland

Paracervical blockade

0.6

6.7

141

2174

S01AX11

ATC

[U] ofloxacin

1.6

6.7

139

855

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.9

6.7

372

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.6

274

1942

D06BB10

ATC

imiquimod; topical

1.4

6.6

298

2144

R23

ICPC

Voice symptom/complaint

1.6

6.6

157

997

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

6.6

276

1961

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

6.6

562

4427

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

6.6

1120

F34.1

ICD-10 Finland

Dysthymia

1.4

6.6

276

1962

DM1AA, ,

SPAT

1.7

6.6

116

684

M76.6

ICD-10 Finland

Achilles tendinitis

1.4

6.6

277

1971

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.6

6.6

149

936

G90.8

ICD-10 Finland

Other disorders of autonomic nervous system

3.8

6.6

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

3.8

6.6

XF405

NOMESCO Finland

Symptom ECG

2.3

6.6

191

C10AA07

ATC

rosuvastatin; oral

1.2

6.6

1299

11129

M23.5

ICD-10 Finland

Chronic instability of knee

2.2

6.5

216

G93.3

ICD-10 Finland

Postviral fatigue syndrome

2.2

6.5

216

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.7

6.5

122

730

N05AB04

ATC

prochlorperazine; systemic, rectal

1.9

6.5

361

H81

ICPC

Excessive ear wax

1.2

6.5

685

5529

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.4

6.5

231

1595

ZXA00

NOMESCO Finland

Right side

1.2

6.5

1181

10047

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

4.0

6.5

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

1.6

6.5

133

816

L30.8

ICD-10 Finland

Other specified dermatitis

1.6

6.5

158

1010

E66.9

ICD-10 Finland

Obesity, unspecified

1.4

6.5

251

1761

L04AX03

ATC

methotrexate; systemic

1.3

6.4

564

4457

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.2

6.4

944

7877

R05CB02

ATC

bromhexine; systemic

2.2

6.4

224

WX723

NOMESCO Finland

CPAP therapy

1.5

6.4

206

1395

H53.2

ICD-10 Finland

Diplopia

1.6

6.4

150

950

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

6.4

980

8213

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

1.5

6.4

200

1348

L14

ICPC

Leg/thigh symptom/complaint

1.3

6.4

436

3341

R2110

NOMESCO Finland

Giving the first information

1.3

6.4

447

3437

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.4

6.4

259

1833

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.2

6.3

855

7077

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

6.3

292

2109

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

1.5

6.3

198

1334

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

1.8

6.3

471

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

6.3

214

1465

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

1.9

6.3

366

R03AC19

ATC

olodaterol

3.9

6.3

SPAT1389

SPAT

Visit based on need for special support

1.3

6.3

375

2819

NHE20

NOMESCO Finland

Plastic repair of capsule or ligament of ankle joint with transplant

2.6

6.3

135

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.1

6.3

259

DMW00

NOMESCO Finland

Intubation of maxillary antrum

3.2

6.3

F01

ICPC

Eye pain

1.5

6.3

211

1443

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.3

6.2

430

3297

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

6.2

556

4403

G03DB01

ATC

dydrogesterone; oral

1.2

6.2

908

7572

SAB02

NOMESCO Finland

Oral and dental health check by dental hygienist or dental assistant

1.2

6.2

1029

8680

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

6.2

276

1982

S01KA02

ATC

hypromellose; ophthalmic

2.0

6.2

313

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

6.2

321

2362

M05BA04

ATC

alendronic acid; oral

1.5

6.2

203

1380

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

6.2

295

2143

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.6

6.2

120

726

Z50.5

ICD-10 Finland

Speech therapy

1.7

6.2

113

674

B27.9

ICD-10 Finland

Infectious mononucleosis, unspecified

1.9

6.2

369

M03BX01

ATC

baclofen; systemic

1.7

6.2

102

592

SPAT1248

SPAT

OTHER EXAMINATIONS, PROCEDURES, TREATMENT ETC.

2.4

6.1

166

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.4

6.1

278

2003

P72

ICPC

Schizophrenia

0.4

6.1

771

J33.1

ICD-10 Finland

Polypoid sinus degeneration

6.9

6.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

6.1

291

2114

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

1.8

6.1

462

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.4

6.1

269

1930

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.2

6.1

1496

13028

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

6.1

573

4567

E73.8

ICD-10 Finland

Other lactose intolerance

2.8

6.1

103

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.1

6.1

2855

25943

KH1AD

NOMESCO Finland

CT of urinary organs

1.5

6.1

159

1033

N02CD06

ATC

rimegepant; oral

2.5

6.1

149

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.6

6.1

136

853

Z57.2

ICD-10 Finland

Occupational exposure to dust

5.3

6.1

130

Kela drug reimbursment

Malignant tumour

0.6

6.1

116

1825

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

1.7

6.1

100

580

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.2

6.1

660

5347

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.2

6.1

230

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

6.1

455

3530

OAB95, ,

SPAT

1.2

6.0

721

5898

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

3.9

6.0

NGE10

NOMESCO Finland

Incision or suture of capsule of knee joint

2.3

6.0

186

S16

ICPC

Bruise/contusion

1.5

6.0

171

1130

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.5

6.0

198

1348

D01BA02

ATC

terbinafine; oral

1.2

6.0

1280

11026

R05CA10

ATC

expectorants - combinations

1.7

6.0

537

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

229

23.61

315.67

1.1

1.0

0.70

1.67

u/ml

0.46

140

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

423

173

25.21

307.65

1.2

1.1

8.82

11.88

u/ml

0.25

320

110

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1501

2047

8.41

307.65

1.1

1.41

1.07

u/ml

0.93

1011

842

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1082

1627

7.28

307.65

1.1

6.72

5.48

u/ml

0.80

661

658

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

254

107

24.05

307.65

1.1

2.59

2.50

u/ml

0.03

200

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

239

25.72

307.65

1.1

1.0

4.03

2.11

u/ml

0.33

138

(3005322) IgE [Units/volume] in Serum or Plasma

2201

5700

4.66

307.65

1.5

1.3

475.39

202.69

u/ml

8.96

2112

5245

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

925

1417

7.03

307.65

1.1

1.0

0.48

0.31

u/ml

0.64

421

324

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1716

2386

8.44

307.65

1.2

1.1

2.47

2.57

u/ml

0.10

1111

1171

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1168

1755

7.35

307.65

1.1

6.76

3.40

u/ml

4.29

776

816

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

264

36.19

307.65

1.0

0.26

0.06

u/ml

2.41

162

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

373

323

11.82

307.65

1.1

1.0

16.64

11.56

u/ml

1.97

209

204

(3003888) Timothy IgE Ab [Units/volume] in Serum

1708

2100

9.56

307.65

1.2

1.1

8.13

5.92

u/ml

3.61

1287

1071

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1609

2022

9.25

307.65

1.2

1.1

2.88

1.86

u/ml

2.58

1120

983

(3011841) English Walnut IgE Ab [Units/volume] in Serum

272

100

27.61

307.65

1.1

5.62

6.30

u/ml

0.08

215

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

418

522

8.22

307.51

1.3

1.2

5.23

1.73

u/ml

3.88

262

260

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

196

29.91

293.90

1.1

—

(4200892) Spirometry reversibility

1211

3946

3.32

289.14

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

203

21.99

272.23

1.1

1.0

0.51

0.34

u/ml

0.22

124

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

173

28.49

255.44

1.0

1.63

2.44

u/ml

0.17

126

(3012494) Peanut IgE Ab [Units/volume] in Serum

319

372

8.72

247.79

1.2

1.1

21.13

3.13

u/ml

1.25

249

222

(3027231) Wheat IgE Ab [Units/volume] in Serum

251

229

11.08

233.29

1.2

1.1

8.75

2.07

u/ml

0.87

210

205

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

150

29.48

224.03

1.0

1.03

3.32

u/ml

0.37

116

(3019420) Tryptase [Mass/volume] in Serum or Plasma

310

429

7.34

208.27

1.3

1.5

5.25

6.47

ug/l

1.50

280

381

(3013115) Eosinophils [#/volume] in Blood

5483

38763

1.93

206.26

5.9

6.7

0.23

0.18

e9/l

44.51

4892

34642

(3000492) Spirometry study

1655

7633

2.38

198.42

1.5

1.4

—

(3001604) Monocytes [#/volume] in Blood

5256

37378

1.87

185.94

5.7

6.4

0.54

e9/l

0.47

4639

32959

(3006315) Basophils [#/volume] in Blood

5261

37434

1.87

185.69

5.7

6.4

0.04

e9/l

6.31

4638

32949

(3019198) Lymphocytes [#/volume] in Blood

5423

39041

1.86

183.46

5.7

6.3

2.02

2.01

e9/l

0.31

4908

35234

(3019069) Monocytes/100 leukocytes in Blood

5036

35504

1.85

181.40

6.0

6.7

8.05

8.13

1.33

4746

33588

(3006504) Eosinophils/100 leukocytes in Blood

5009

35263

1.85

181.18

5.7

6.4

3.42

2.79

50.75

4709

33305

(3022096) Basophils/100 leukocytes in Blood

4870

34000

1.85

180.83

5.8

6.5

0.70

0.67

4.76

4558

31973

(3018010) Neutrophils/100 leukocytes in Blood

5157

36674

1.85

180.10

5.6

6.2

54.42

55.46

9.40

4876

34820

(3002030) Lymphocytes/100 leukocytes in Blood

5202

37222

1.84

176.73

5.8

6.3

30.62

30.41

0.83

4917

35362

(40760892) CBC W Ordered Manual Differential panel - Blood

4979

35273

1.82

173.53

6.1

6.8

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

118

20.32

153.39

1.0

23.95

20.48

u/ml

0.16

100

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

248

383

6.54

150.30

1.1

13.05

10.69

u/ml

0.36

100

(3013650) Neutrophils [#/volume] in Blood by Automated count

5616

42731

1.72

139.15

7.2

9.1

3.79

3.94

e9/l

6.39

4941

37561

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

121

15.50

138.20

1.1

1.0

11.66

7.84

u/ml

0.64

102

(3020874) Milk IgE Ab [Units/volume] in Serum

346

834

4.21

126.60

1.3

1.1

8.69

1.03

u/ml

2.04

221

303

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1288

6471

2.12

120.70

3.8

3.3

31.50

31.90

0.66

921

4878

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

106

14.68

117.68

1.8

1.3

13.80

5.32

u/ml

0.62

(3013707) Erythrocyte sedimentation rate by Westergren method

6500

52684

1.69

115.64

4.2

3.7

8.62

8.99

mm/h

2.26

6058

49443

(3016031) Almond IgE Ab [Units/volume] in Serum

111

13.03

115.09

1.0

1.1

1.40

0.53

u/ml

1.75

(3014599) Egg white IgE Ab [Units/volume] in Serum

326

827

3.99

111.24

1.3

1.1

12.02

4.21

u/ml

0.93

199

229

(3015076) Soybean IgE Ab [Units/volume] in Serum

302

746

4.09

106.86

1.1

1.0

1.19

1.50

u/ml

0.14

189

202

(3007164) IgA [Mass/volume] in Serum or Plasma

2801

18987

1.65

97.23

1.6

1.4

2.09

2.11

g/l

0.26

1671

11981

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3123

22032

1.59

90.65

1.4

1.55

1.83

u/ml

0.59

764

6029

(3013512) EKG study

2154

14481

1.61

73.69

2.9

2.8

—

(3019225) pH of Specimen

937

4974

1.95

73.31

3.5

3.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

12.13

71.58

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

11.13

70.55

1.1

4.05

0.03

u/ml

2.79

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8520

77564

1.80

65.99

11.6

10.3

18.33

20.29

mg/l

7.23

6649

58472

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

127

7.37

64.45

1.0

0.02

0.01

u/ml

0.37

(44813793) Dust mix specific IgE antibody measurement

243

740

3.30

63.08

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

1827

12209

1.59

62.73

2.8

2.7

94.90

118.17

ug/g

2.95

1408

9744

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3000

22336

1.48

62.10

1.9

1.7

100.84

98.41

pmol/l

1.99

1615

12203

(40768797) Stomach Pathology biopsy report

1327

8255

1.68

60.54

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

1663

11135

1.57

55.87

1.5

1.4

500.13

566.81

titre

0.64

300

2098

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

582

2867

2.07

55.74

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3271

25296

1.42

53.20

1.9

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6947

61158

1.45

53.11

4.4

4.0

14.45

14.43

pmol/l

0.29

6352

56702

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7819

70511

1.53

52.52

5.1

4.5

2.01

1.92

mu/l

0.15

7291

66664

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

542

2665

2.07

52.11

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

203

633

3.21

50.73

1.3

1.1

—

(36660697) Celiac disease serology panel - Serum

1248

8013

1.62

49.52

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

18.40

48.43

1.0

1.49

0.33

u/ml

1.04

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4693

39031

1.37

47.52

3.1

2.9

85.40

80.59

ug/l

0.29

4408

37019

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1859

13173

1.49

47.05

1.4

1.3

21.36

25.91

iu/ml

0.90

492

4050

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

203

663

3.07

46.94

1.1

5.80

7.19

iu/ml

0.31

167

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2155

15764

1.45

46.21

2.0

0.82

0.98

mg/l

1.59

1502

11357

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1139

7273

1.62

45.99

2.1

354.91

374.01

nmol/l

2.85

1035

6747

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1764

12454

1.49

45.25

1.3

7.47

9.23

u/ml

0.73

652

5221

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3649

29340

1.37

44.84

2.5

2.4

74.81

72.39

nmol/l

5.98

3357

27478

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5867

50789

1.37

44.70

6.6

6.7

75.74

76.53

u/l

0.67

5483

48103

(3019550) Sodium [Moles/volume] in Serum or Plasma

7995

73019

1.50

44.60

10.8

10.5

139.57

139.58

mmol/l

0.06

7745

70996

(3023103) Potassium [Moles/volume] in Serum or Plasma

8012

73244

1.50

44.10

10.9

10.6

3.90

3.91

mmol/l

1.92

7724

70990

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

502

2556

1.99

43.72

1.6

1.8

1.17

1.16

g/l

0.23

475

2453

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1444

2.32

43.34

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

488

2481

1.99

42.67

1.7

1.9

0.22

g/l

0.31

459

2373

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

890

5453

1.67

42.12

2.5

2.3

18.15

21.16

au/ml

0.59

511

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3288

26210

1.36

41.84

5.2

6.3

1.22

mmol/l

3.47

2960

24306

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

835

5043

1.70

41.71

1.3

48.82

46.01

au/ml

0.12

226

(3047007) Chlamydophila sp Ab [Presence] in Serum

331

1468

2.27

41.28

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

187

631

2.96

40.88

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

16.04

39.48

1.0

—

(40758558) Short blood count panel - Blood

2401

18349

1.39

39.11

5.3

7.2

—

(40768804) Tissue Pathology biopsy report

3439

27823

1.34

38.95

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2521

19471

1.38

38.36

2.8

2.6

19.05

50.52

ng/l

1.78

1158

9055

(3028026) IgM [Mass/volume] in Serum or Plasma

761

4588

1.69

38.15

1.8

1.25

1.26

g/l

0.05

693

4285

(3024522) Salmonella sp identified in Specimen by Organism specific culture

202

744

2.72

37.56

1.4

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1221

8282

1.52

37.34

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

145

5.21

37.09

1.0

—

(3000494) Fungus identified in Specimen by Culture

1156

7761

1.54

37.06

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7409

67315

1.39

36.96

9.2

8.7

94.84

94.95

ml/min/173m2

0.16

5954

53945

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

202

751

2.69

36.89

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

200

742

2.70

36.67

1.4

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1220

8332

1.51

36.03

1.7

1.6

1085.93

1165.84

nmol/l

2.43

890

6552

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

199

745

2.67

35.86

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

199

745

2.67

35.86

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

203

769

2.64

35.73

1.4

1.5

—

(3023419) Bacteria identified in Sputum by Culture

163

550

2.96

35.68

2.7

3.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2182

16626

1.38

35.61

2.4

2.2

2.59

2.71

mg/l

2.07

1860

14404

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

535

2977

1.82

35.45

1.6

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

118

328

3.58

35.44

1.2

0.29

g/l

0.09

267

(3004616) Nuclear Ab [Presence] in Serum

210

813

2.58

35.38

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7622

69723

1.40

35.30

4.3

3.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

111

297

3.72

35.26

1.2

111.06

108.70

0.42

104

268

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6152

54504

1.32

35.04

3.1

2.9

35.81

36.76

u/l

0.59

5815

52137

(3005719) IgG [Mass/volume] in Serum or Plasma

921

5975

1.58

34.26

2.5

2.7

10.20

10.36

g/l

0.70

841

5528

(3022145) Colonoscopy Study observation

1052

7062

1.53

33.55

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5739

50538

1.30

33.11

4.1

3.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

348

1720

2.03

32.91

1.2

1.1

14.12

10.92

au/ml

0.22

118

(3024139) IgG subclass 3 [Mass/volume] in Serum

213

863

2.47

32.64

1.4

1.3

0.34

0.37

g/l

0.84

180

607

(3027135) IgG subclass 1 [Mass/volume] in Serum

213

863

2.47

32.64

1.4

1.3

6.45

6.51

g/l

0.13

179

611

(3028192) IgG subclass 2 [Mass/volume] in Serum

213

864

2.47

32.56

1.4

1.3

2.96

2.86

g/l

0.41

180

612

(3021589) Normoblasts [#/volume] in Blood

4021

33868

1.30

32.17

8.0

8.6

0.00

e9/l

1.36

3241

27766

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2103

16151

1.37

32.16

2.1

172.65

224.94

u/l

1.47

1972

15364

(3003327) Ova and parasites identified in Stool by Light microscopy

578

3386

1.73

32.07

1.8

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3513

29080

1.30

31.97

5.7

6.6

1.22

mmol/l

4.13

2997

25062

(4062490) Immunoglobulin typing, IgG

211

864

2.44

31.62

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

893

5856

1.56

31.59

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

468

2611

1.81

30.72

1.9

1.6

14.98

9.55

u/ml

0.30

105

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8576

80582

1.51

30.53

9.0

8.4

26.80

26.68

u/l

0.21

8307

78279

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

336

1712

1.97

29.18

1.5

26.00

10.55

iu/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

11.42

28.69

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5421

47833

1.28

28.51

4.1

3.8

2503.13

1363.18

e6/l

0.55

575

(3013139) Helicobacter pylori Ag [Presence] in Stool

751

4846

1.58

28.42

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

400

2188

1.84

28.00

1.3

66.65

32.25

u/ml

0.89

149

(3007461) Platelets [#/volume] in Blood

9251

88813

1.98

27.61

16.9

15.3

265.61

262.13

e9/l

6.45

9079

86737

(3024980) IgG subclass 4 [Mass/volume] in Serum

280

1364

2.06

27.58

1.6

0.81

0.71

g/l

0.94

241

1049

(3000963) Hemoglobin [Mass/volume] in Blood

9263

88971

2.01

27.56

16.9

15.3

136.77

136.38

g/l

2.27

9185

88000

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

951

6511

1.49

27.33

4.0

4.9

—

(3035941) MCH [Entitic mass]

9257

88913

1.99

27.23

16.8

15.2

29.93

0.04

9178

87941

(3010813) Leukocytes [#/volume] in Blood

9259

88947

1.99

27.09

16.9

15.3

6.72

6.70

e9/l

0.57

9063

86701

(3017732) Neutrophils [#/volume] in Blood

784

5164

1.54

27.04

2.1

2.3

4.39

4.68

e9/l

0.61

610

4483

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7288

66973

1.32

26.92

3.7

3.3

5.59

5.63

mmol/l

1.96

6715

62790

(3026361) Erythrocytes [#/volume] in Blood

9257

88933

1.98

26.90

16.8

15.2

4.59

4.58

e12/l

2.40

9064

86723

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

369

1994

1.86

26.85

1.3

15.47

12.93

u/ml

0.14

319

(3024731) MCV [Entitic volume]

9255

88911

1.97

26.84

16.8

15.2

89.47

89.49

0.17

9175

87943

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

166

661

2.51

26.48

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

9238

88721

1.93

26.38

16.9

15.3

40.73

40.88

0.48

8972

84720

(3021960) Folate [Moles/volume] in Serum or Plasma

1588

11992

1.37

26.35

1.5

1.4

20.15

20.31

nmol/l

0.18

1370

10687

(40761511) CBC panel - Blood by Automated count

8666

81944

1.49

26.22

10.4

9.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

386

2146

1.81

25.63

1.8

1.7

465.45

370.69

titre

0.15

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

361

1972

1.84

25.39

1.3

11.42

7.84

u/ml

0.15

204

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6618

60209

1.28

25.38

4.5

4.1

37.40

37.56

mmol/mol

0.72

6163

57048

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

275

1382

1.99

24.88

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

508

3095

1.66

24.29

3.6

5.7

24.32

24.39

mmol/l

0.25

480

2986

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

474

2845

1.68

24.00

1.8

1.9

38.87

39.32

u/l

0.21

427

2636

(40768443) Skin Pathology biopsy report

437

2577

1.71

23.64

1.2

—

(3022313) Gas panel - Capillary blood

525

3251

1.63

23.53

3.6

5.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3751

32196

1.25

22.92

4.8

5.7

11.06

10.94

umol/l

0.15

3489

30268

(3038026) Centromere Ab [Units/volume] in Serum

128

488

2.61

22.40

1.3

1.2

30.48

44.59

u/ml

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1359

10283

1.36

21.90

2.7

3.0

737.00

760.87

ng/l

0.06

1014

8296

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

324

1793

1.81

21.88

1.7

2.0

10.44

10.41

mg/l

0.03

293

1703

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

125

477

2.61

21.85

1.3

1.2

33.20

53.04

u/ml

—

(3009343) pH of Capillary blood

646

4277

1.53

21.67

3.5

5.4

7.41

0.03

462

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2055

16505

1.29

21.66

2.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

125

480

2.59

21.58

1.3

1.2

106.13

41.40

u/ml

—

(3020961) Endomysium IgA Ab [Titer] in Serum

767

5272

1.47

21.44

1.2

102.05

211.68

titre

1.38

167

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

648

4313

1.52

21.20

3.5

5.3

5.04

5.10

kpa

1.29

622

4138

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

630

4177

1.52

20.98

3.5

5.4

0.82

1.26

mmol/l

3.09

442

2978

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

106

381

2.77

20.84

2.0

2.1

207.74

100.38

ug/l

0.24

101

353

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

108

396

2.71

20.45

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

286

1564

1.83

20.10

1.3

1.61

3.30

u/ml

0.92

117

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

118

461

2.55

19.70

1.3

1.2

18.38

17.57

u/ml

0.02

(3015377) Calcium [Moles/volume] in Serum or Plasma

2402

19878

1.26

19.49

2.4

3.0

2.35

mmol/l

0.28

2070

18049

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

173

812

2.12

18.93

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

7.57

18.36

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

451

2864

1.58

18.22

1.1

3.55

5.32

u/ml

0.82

431

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

399

2462

1.63

18.16

1.7

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1838

14850

1.27

18.03

2.3

2.4

2662.88

2815.32

umol/l

0.08

1626

13544

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

208

1068

1.94

17.80

1.5

1.3

103.33

183.16

titre

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2404

20078

1.24

17.66

2.4

2.5

54.35

57.68

u/l

2.49

2192

18670

(3044640) Blood type and Crossmatch panel - Blood

2576

21703

1.24

17.41

2.1

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1148

8757

1.33

17.25

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

132

582

2.26

16.92

1.8

2.0

16.90

26.04

mg/l

2.09

163

(3013826) Glucose [Moles/volume] in Serum or Plasma

4285

38103

1.20

16.44

4.1

4.5

6.30

6.33

mmol/l

0.27

3928

34534

(3022948) Iron [Moles/volume] in Serum or Plasma

1240

9626

1.31

16.42

2.3

2.4

14.75

14.44

umol/l

0.85

1164

9055

(3024561) Albumin [Mass/volume] in Serum or Plasma

2944

25295

1.22

16.16

4.5

4.9

37.40

37.07

g/l

2.87

2720

23741

(3015171) Extractable nuclear Ab [Units/volume] in Serum

477

3184

1.50

15.39

1.3

0.41

1.00

u/ml

1.75

254

(3045683) HLA typing for celiac disease panel - Blood or Tissue

141

665

2.11

15.33

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

4.32

15.09

1.1

1.0

1.24

0.09

u/ml

2.09

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1123

8711

1.31

14.87

2.3

2.4

2.50

2.47

g/l

1.14

1047

8111

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1819

14972

1.25

14.87

1.6

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7511

70674

1.23

14.77

3.9

3.6

2.86

2.87

mmol/l

0.51

7030

67104

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

974

7428

1.33

14.55

1.3

1.2

117.46

148.25

iu/ml

1.73

348

2819

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

371

2379

1.56

14.41

2.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

279

1669

1.67

14.41

1.4

317.43

312.07

ug/g

0.14

128

866

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7421

69807

1.22

14.26

3.7

3.4

1.45

1.47

mmol/l

2.09

6956

66500

(42529406) Shigella sp [Presence] in Stool by Culture

358

2287

1.57

14.15

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

356

2272

1.57

14.13

1.1

—

(3023368) Bacteria identified in Blood by Culture

1687

13879

1.24

13.73

3.6

4.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

315

1977

1.59

13.45

1.4

18.31

20.00

u/l

0.46

245

1659

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7455

70289

1.22

13.30

3.7

3.4

4.72

4.74

mmol/l

0.68

7006

67103

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

349

2258

1.55

13.06

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

334

2147

1.56

12.87

2.0

1.8

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

18.79

12.79

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1019

7966

1.29

12.65

2.4

2.5

24.06

0.00

928

6969

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

220

1281

1.71

12.62

2.5

2.6

—

(1002224) Polysomnography panel

508

3570

1.43

12.60

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2370

20339

1.20

12.51

2.3

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

376

2498

1.51

12.46

2.3

2.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1204

1.72

12.21

2.7

2.1

0.64

0.57

g/l

0.15

176

1094

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

411

2792

1.47

12.21

1.6

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

265

1635

1.62

12.18

1.1

3.56

3.15

u/ml

0.17

122

819

(3025941) Bacteria identified in Stool by Culture

664

4911

1.36

12.15

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7138

67189

1.19

12.14

3.4

3.1

1.25

1.24

mmol/l

0.78

6660

63798

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

372

2.32

12.11

4.0

4.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

283

1781

1.59

11.99

1.2

1.3

43.29

39.58

u/ml

0.10

163

(3033658) Prothrombin time (PT) actual/Normal

1986

16822

1.21

11.97

3.6

4.1

96.79

94.68

3.98

1926

16372

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

560

4041

1.39

11.94

1.1

37.57

10.89

u/ml

0.31

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

733

5519

1.34

11.92

2.8

3.4

4.71

4.64

pmol/l

0.60

640

5003

(3017446) Testosterone [Moles/volume] in Serum or Plasma

705

5281

1.34

11.87

2.4

2.1

11.93

11.45

nmol/l

0.81

641

4842

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

193

1103

1.74

11.87

2.5

2.0

38.54

38.89

g/l

0.35

165

1016

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

283

1786

1.58

11.85

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

483

3408

1.42

11.73

2.4

2.5

67.34

67.11

g/l

0.31

430

3196

(3048929) Epstein Barr virus Ab [Presence] in Serum

646

4794

1.35

11.57

1.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2567

22326

1.18

11.47

2.5

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

244

2.60

11.42

1.5

1.3

27.42

17.59

u/ml

0.40

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

229

2.64

11.23

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

178

1019

1.74

10.92

1.1

1.41

1.45

g/l

0.77

153

935

(3022217) INR in Platelet poor plasma by Coagulation assay

2666

23340

1.18

10.90

7.7

8.1

1.09

1.11

inr

0.51

783

7696

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

1349

1.64

10.90

2.4

2.0

2.85

2.91

g/l

0.42

195

1263

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

194

2.76

10.83

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

212

2.66

10.70

1.6

1.3

23.33

65.22

titre

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

174

1006

1.72

10.33

2.7

2.1

0.00

g/l

-0.00

158

953

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

175

1015

1.72

10.27

2.7

2.1

0.01

0.00

g/l

0.45

158

955

(3024891) Influenza virus A+B Ag [Presence] in Specimen

366

2517

1.45

10.25

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

725

5591

1.30

9.94

3.1

3.5

1.58

1.66

1.35

619

5071

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

139

2.99

9.80

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1052

8507

1.25

9.80

2.0

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

688

5282

1.31

9.75

3.7

4.5

0.09

0.11

0.47

176

1414

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

546

4058

1.35

9.70

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1406

1.59

9.68

2.4

2.0

—

(36304419) Bacteria [Presence] in Urine

2056

17764

1.18

9.66

2.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

1291

1.61

9.66

2.5

2.0

10.01

10.28

g/l

0.48

180

1199

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1407

1.59

9.65

2.4

2.0

6.90

7.23

g/l

2.38

197

1320

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

185

1110

1.66

9.60

2.6

2.0

0.01

g/l

0.07

167

1047

(3008898) HLA-B27 [Presence]

529

3928

1.35

9.47

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1406

1.58

9.46

2.4

2.0

3.73

3.63

g/l

0.57

197

1321

(3003740) Influenza virus B Ag [Presence] in Specimen

297

1997

1.48

9.37

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

137

762

1.79

9.35

2.3

3.0

557.61

537.38

e6/l

0.19

113

604

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

728

5682

1.29

9.11

2.9

2.7

0.23

0.22

g/l

1.79

679

5350

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

365

2569

1.42

9.06

1.9

1.7

39.91

39.52

nmol/l

0.09

357

2518

(4146454) Self-monitoring of blood glucose

414

2.06

9.05

3.5

2.7

—

(3017181) Myelocytes/100 leukocytes in Blood

708

5513

1.29

9.03

3.7

4.4

0.71

0.85

0.69

196

1642

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

1.32

1.02

mg/l

0.27

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

3.10

2.70

mg/l

0.14

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

3.99

3.98

mg/l

0.00

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

2.19

1.91

mg/l

0.14

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

1.26

1.21

mg/l

0.04

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

3.55

3.30

mg/l

0.08

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

2.07

1.90

mg/l

0.07

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

1.24

1.59

mg/l

0.31

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

126

2.98

8.87

1.8

1.7

1.06

1.28

mg/l

0.41

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

134

755

1.76

8.78

2.3

3.0

0.21

0.20

e9/l

0.12

113

607

(3002523) Influenza virus A Ag [Presence] in Specimen

294

2000

1.47

8.77

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

105

549

1.90

8.75

2.2

2.5

1.91

1.77

umol/l

1.21

526

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

513

3838

1.34

8.75

1.6

3.86

4.06

mg/l

0.22

375

2659

(3025159) Blasts/100 leukocytes in Blood

657

5093

1.29

8.68

3.8

4.5

0.61

0.31

0.20

142

1212

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

123

2.98

8.61

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

207

1314

1.57

8.57

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

207

1315

1.57

8.55

1.2

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

129

2.92

8.52

1.8

1.7

1.20

1.29

mg/l

0.06

(3002179) Metamyelocytes/100 leukocytes in Blood

657

5106

1.29

8.51

3.3

4.2

0.51

0.58

0.33

172

1445

(3015736) pH of Urine

3338

30155

1.14

8.43

2.8

2.9

6.05

5.97

1.13

362

3262

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

289

2.23

8.40

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

547

4173

1.31

8.15

1.6

1.5

8.17

8.57

u/l

0.36

435

3339

(3018095) Leukocytes [#/volume] in Urine

2696

24045

1.15

8.15

3.5

46.10

67.68

e6/l

1.52

1749

15885

(3030467) Casts [#/volume] in Urine by Automated count

2023

17679

1.16

8.07

3.0

2.9

0.19

0.30

e6/l

4.58

1467

13101

(3009508) Creatinine [Moles/volume] in Urine

2062

18064

1.16

7.95

3.3

3.4

8.32

mmol/l

0.01

1773

16076

(3005011) Chlamydia sp Ab [Titer] in Serum

153

2.65

7.75

1.3

1.4

—

(3011412) CD3 cells [#/volume] in Blood

156

951

1.63

7.70

2.3

2.9

1.44

1.33

e9/l

0.82

135

803

(3023520) Reticulocytes [#/volume] in Blood

508

3868

1.31

7.69

2.5

3.2

69.86

70.72

e9/l

0.20

357

2782

(3017958) Strawberry IgE Ab [Units/volume] in Serum

6.84

7.67

1.0

0.29

0.05

u/ml

0.72

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1368

11640

1.19

7.53

1.6

20819242.07

35038511.80

pmol/l

0.63

1148

10109

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

680

1.74

7.49

1.1

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

382

2806

1.36

7.40

1.6

0.11

6.19

iu/ml

0.52

557

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1110

9289

1.20

7.35

2.1

2.6

2.41

2.42

mmol/l

1.73

944

8102

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

118

679

1.72

7.26

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

118

680

1.72

7.23

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

2.69

7.22

4.1

4.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

181

1162

1.55

7.21

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

479

1.86

7.19

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1101

9230

1.20

7.15

3.3

4.6

0.83

0.82

mmol/l

1.28

1017

8754

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

726

5840

1.25

7.08

3.3

4.6

228.21

238.80

u/l

1.22

676

5557

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

365

4784

0.74

7.06

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

395

5116

0.75

7.03

1.5

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

116

671

1.72

7.02

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

672

5364

1.25

7.02

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

116

673

1.71

6.95

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

173

1112

1.55

6.87

1.4

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

115

670

1.70

6.80

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

306

4093

0.73

6.78

1.4

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

251

1748

1.43

6.71

2.1

2.6

433.35

448.02

ug/l

0.02

212

1584

(3008757) Leukocyte morphology finding [Identifier] in Blood

112

658

1.69

6.45

3.1

3.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1855

16348

1.15

6.44

1.6

1.40

1.38

mmol/l

0.44

1630

14326

(3042631) Mycobacterium sp identified in Specimen

469

1.82

6.41

2.9

2.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

197

1325

1.48

6.35

1.7

608.00

2525.45

titre

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

222

1529

1.44

6.33

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

3.35

6.26

1.1

0.86

0.53

u/ml

0.27

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

344

2558

1.34

6.21

2.3

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

707

5754

1.23

6.21

1.7

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

104

608

1.70

6.12

3.0

2.9

40622.33

40828.19

ug/l

0.05

104

608

(3012516) Albumin [Mass/volume] in Urine

1506

13119

1.16

6.12

3.4

543.23

409.71

mg/l

0.41

902

8677

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

344

2566

1.34

6.09

1.2

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

197

1338

1.46

6.06

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.20

5.85

1.1

1.06

0.14

u/ml

1.04

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1222

10517

1.17

5.81

2.6

0.77

1.06

e6/l

2.48

656

5690

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

229

1614

1.41

5.79

2.3

1.8

193.73

192.16

pmol/l

0.07

222

1538

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

4.94

5.79

1.1

1.0

0.84

0.13

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

337

1.91

5.71

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

763

6316

1.21

5.68

2.2

2.5

34.99

44.71

u/l

0.64

646

5460

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

4.80

5.65

1.0

0.47

0.06

u/ml

1.10

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

918

7748

1.19

5.53

2.5

3.2

5.79

6.63

umol/l

1.01

787

6582

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

220

2.11

5.48

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

220

2.11

5.48

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

406

1.81

5.47

1.4

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.76

5.46

2.7

1.7

38.79

43.83

umol/l

0.24

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

111

682

1.61

5.44

1.2

1.3

373.08

213.22

titre

0.52

143

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

208

2.14

5.42

1.0

1.2

—

(3027020) Pear IgE Ab [Units/volume] in Serum

15.81

5.37

1.0

0.51

0.34

u/ml

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

5.11

5.31

1.0

0.77

0.15

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

303

2275

1.33

5.19

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

7279

69858

1.12

5.19

12.9

12.7

14.31

14.32

0.03

7200

68608

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1431

12562

1.15

5.18

1.6

1.7

1.34

1.36

0.57

1269

11350

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2697

24610

1.11

5.18

3.0

3.2

30.15

31.40

u/l

0.61

2560

23518

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

222

1591

1.39

5.14

3.0

3.8

55.15

56.06

0.64

222

1591

(3004716) Salmonella sp identified in Stool by Organism specific culture

712

5916

1.20

5.11

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

321

2440

1.31

5.05

1.2

1.4

248.38

233.82

u/ml

0.43

185

1499

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

706

5870

1.20

5.04

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1159

10046

1.16

5.01

2.7

3.41

3.54

e6/l

0.13

592

5220

(3002582) Erythrocytes [#/volume] in Urine

2150

19410

1.12

4.97

3.0

47.85

79.75

e6/l

1.05

1596

14585

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

121

2.45

4.96

1.1

1.2

20.80

29.40

u/ml

—

(3018418) pH of Serum or Plasma

1862

16677

1.13

4.92

3.4

3.9

7.40

1.33

353

3269

(3029075) Extractable nuclear Ab panel - Serum

271

1.94

4.90

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

499

4020

1.24

4.88

3.7

4.5

67.91

75.14

ng/l

1.56

444

3654

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

147

988

1.48

4.86

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

301

2281

1.31

4.85

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1020

8779

1.16

4.84

3.7

3.4

1.66

1.77

ug/l

0.20

899

8022

(3034770) Mitochondria Ab [Titer] in Serum

289

2180

1.32

4.82

1.2

1.4

2240.00

993.71

titre

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

207

2.06

4.71

1.1

—

(3026782) Osmolality of Urine

1415

12495

1.14

4.68

2.6

538.80

551.11

mosm/kgh2o

1.08

1177

10742

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

269

1.91

4.67

1.2

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

138

928

1.47

4.58

2.3

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

755

1.52

4.51

2.2

2.7

—

(3000850) Epithelial cells [#/volume] in Urine

1493

13263

1.13

4.49

2.5

6.74

7.27

e6/l

0.66

1300

11823

(3010838) Calcium [Moles/time] in 24 hour Urine

155

1071

1.44

4.47

1.9

2.0

5.16

5.34

mmol/24h

0.26

137

978

(3002256) Pathology report gross observation

961

8285

1.16

4.47

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

136

917

1.47

4.46

1.7

1.6

—

(3006462) Nitrate [Presence] in Urine

309

1.83

4.45

3.1

2.4

—

(3045424) Erythrocytes [Presence] in Urine

163

1138

1.42

4.45

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

275

1.87

4.39

1.2

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

3937

36834

1.09

4.37

3.1

3.2

0.01

0.00

estimate

0.24

709

7182

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

241

1.93

4.36

2.5

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1533

13673

1.13

4.31

4.0

11.20

11.75

mg/mmol

0.09

911

9071

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

4.94

4.26

1.0

0.08

0.01

u/ml

0.89

(3014271) Vancomycin [Susceptibility]

125

2.29

4.20

2.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

396

1.70

4.19

1.2

119.87

107.69

1.69

355

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

280

1.84

4.17

1.2

1.1

61.50

50.99

u/ml

0.54

273

(3003129) Base excess in Capillary blood by calculation

101

2.45

4.16

1.1

1.5

-0.43

0.66

mmol/l

1.34

(3021601) Nitrite [Presence] in Urine by Test strip

3906

36589

1.09

4.15

4.3

0.00

estimate

2.33

725

7379

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

375

1.72

4.15

1.2

100.56

95.18

0.60

164

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

557

1.58

4.14

1.6

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

433

3504

1.23

4.12

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

474

1.63

4.10

2.2

3.0

287.74

262.21

e6/l

0.25

285

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

785

0.54

4.10

13.8

14.3

820.00

816.33

nmol/l

0.02

757

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

558

4633

1.20

4.09

7.0

9.6

24.66

mmol/l

0.02

553

4609

(3011436) Histone Ab [Units/volume] in Serum

133

2.23

4.08

1.0

1.1

—

33.80

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

5.81

4.08

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

102

663

1.52

4.03

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.50

4.01

1.6

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

387

1.69

3.99

1.1

98.97

94.75

0.82

166

(3041672) Baker's yeast Ab [Presence] in Serum

2.47

3.93

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

405

3277

1.23

3.88

2.8

2.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

159

1135

1.39

3.87

2.7

3.0

23.82

22.66

nmol/l

0.54

152

1098

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

194

1431

1.35

3.85

1.3

4.24

4.35

u/ml

0.05

642

(3023323) Follitropin [Units/volume] in Serum or Plasma

779

6690

1.16

3.84

1.5

1.4

19.15

22.56

iu/l

2.71

663

5642

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

600

5048

1.18

3.81

2.6

2.4

0.60

0.65

ug/l

0.43

315

2629

(3037756) Immunofixation for Serum or Plasma

640

1.52

3.81

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

100

2.37

3.77

1.8

1.5

0.38

0.47

ug/l

0.46

(3017143) Hepatitis C virus Ab [Presence] in Serum

1550

13948

1.12

3.72

1.6

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

100

660

1.50

3.71

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

193

1.95

3.67

1.4

1.5

9.67

8.76

ug/l

0.64

193

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

458

1.60

3.66

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

286

2248

1.26

3.58

1.3

1.4

107.50

118.79

titre

0.13

231

(3021788) Differential panel - Synovial fluid

132

928

1.41

3.55

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

994

8758

1.13

3.41

2.4

2.8

29.39

29.57

0.51

953

8492

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

330

2652

1.24

3.41

2.9

3.4

159.96

167.40

1.09

313

2526

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

257

1.77

3.35

1.3

1.4

10.41

12.23

u/l

1.23

251

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

244

1.78

3.29

1.2

1.1

74.73

74.75

0.00

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1107

9855

1.12

3.22

3.1

3.0

197.38

505.78

ng/l

5.52

587

5596

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.75

3.13

1.0

1.1

0.02

0.22

u/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

470

1.54

3.10

2.6

2.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

129

928

1.38

3.08

1.3

5.05

5.91

umol/l

2.10

122

866

(3034860) Kappa light chains.free [Mass/volume] in Serum

134

970

1.37

3.08

3.7

3.2

38.45

51.85

mg/l

0.85

113

779

(3041806) Other cells [#/volume] in Blood by Manual count

132

955

1.37

3.05

1.7

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

134

972

1.37

3.05

3.7

3.2

26.50

45.60

mg/l

1.47

113

783

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

280

1.70

3.04

1.8

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

3870

36565

1.08

3.02

3.1

3.2

0.00

estimate

2.19

737

7484

(3044927) Protein electrophoresis panel - Urine

311

1.65

3.01

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

138

2.01

2.99

1.2

1.3

243.45

306.93

pmol/l

0.83

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.76

2.99

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1808

16575

1.09

2.98

3.1

3.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

142

1045

1.35

2.96

1.4

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

180

2285

0.77

2.96

1.7

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

571

4895

1.16

2.95

1.4

1.3

231.23

229.17

miu/ml

0.05

279

2428

(3003458) Phosphate [Moles/volume] in Serum or Plasma

891

7876

1.13

2.93

5.5

7.1

1.11

1.10

mmol/l

0.81

822

7433

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

414

1.55

2.92

1.8

1.6

2.08

2.75

nmol/l

0.31

333

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

207

0.33

2.91

5.4

7.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.71

2.91

1.0

1.5

0.20

1.09

umol/24h

—

(3012501) Base excess in Blood by calculation

175

1332

1.30

2.89

2.9

4.0

2.29

2.07

mmol/l

0.45

829

(3010421) pH of Blood

201

1558

1.28

2.89

2.9

4.0

7.42

7.41

0.89

184

1409

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

778

6832

1.14

2.85

3.0

3.1

21.25

21.16

0.05

239

2369

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

476

4035

1.17

2.85

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

279

1.67

2.82

1.8

2.0

—

(3036489) Thrombin time

375

3121

1.19

2.79

2.5

3.0

21.47

21.23

0.35

318

2656

(3016330) Potassium [Moles/time] in 24 hour Urine

115

2.06

2.78

1.2

1.3

—

99.48

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

129

946

1.35

2.77

3.8

3.1

1.28

1.86

ratio

0.57

107

(46235355) HIV 1 and 2 tests - Meaningful Use set

2986

28021

1.08

2.75

2.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

111

796

1.38

2.75

1.3

1.2

20.71

32.31

nmol/l

—

(3019174) dRVVT (LA screen)

2.20

2.71

1.3

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

245

1.70

2.70

1.2

1.1

82.00

87.52

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

115

833

1.37

2.69

1.4

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

188

1466

1.27

2.61

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

139

1.92

2.59

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

491

1.47

2.59

2.3

3.1

57.08

53.69

0.69

424

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

459

1.49

2.58

2.6

3.4

1.04

1.51

ug/l

0.79

436

(3044290) Cell count panel - Cerebral spinal fluid

229

1832

1.24

2.56

1.2

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

412

1.51

2.56

2.6

2.3

9.93

9.53

mg/l

0.23

338

(1616796) Gas panel - Central venous blood

169

1308

1.28

2.51

3.1

3.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

191

1503

1.26

2.48

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

187

1469

1.26

2.47

1.6

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

292

2407

1.20

2.45

2.1

2.5

4.34

6.18

umol/l

5.03

215

1794

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

299

2472

1.20

2.43

9.2

11.0

24.30

24.13

mmol/l

0.56

289

2414

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.24

2.43

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method

605

5288

1.14

2.42

2.8

2.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

201

1.72

2.41

2.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

331

1.55

2.40

1.2

1.4

80.87

91.72

nmol/24h

0.47

331

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

107

782

1.35

2.40

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

112

825

1.34

2.39

1.2

1.3

—

(3001556) Androgen free Index in Serum or Plasma

209

1.70

2.39

1.4

1.2

—

(3016038) Potassium [Moles/volume] in Urine

356

1.53

2.37

1.6

2.0

31.42

35.77

mmol/l

0.64

333

(3001964) Herpes simplex virus Ag [Presence] in Specimen

255

1.63

2.36

1.5

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

642

1.39

2.35

1.2

1.4

177.35

194.65

pmol/l

0.43

642

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

668

1.38

2.33

1.1

290.26

287.43

mg/l

0.14

616

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

270

2223

1.20

2.32

1.3

1.6

—

(3000991) Gas panel - Venous blood

609

5343

1.13

2.31

7.5

9.3

—

(3044889) 12 lead EKG panel

4560

43595

1.06

2.29

2.9

2.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

691

6117

1.12

2.27

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

102

748

1.35

2.26

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

318

2664

1.18

2.26

3.2

3.8

3.34

3.43

g/l

0.64

304

2523

(3000475) Leukocytes [#/volume] in Synovial fluid

148

1145

1.28

2.25

1.6

1.7

11079.31

11463.68

e6/l

0.03

104

841

(3028300) Cannabinoids [Presence] in Urine

861

7724

1.11

2.24

2.1

—

(3027008) Opiates [Presence] in Urine

859

7708

1.11

2.22

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

443

3816

1.15

2.22

4.8

6.2

24.10

23.93

mmol/l

0.58

434

3771

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

393

3356

1.16

2.21

1.9

2.1

6.92

6.79

ug/l

0.05

330

2965

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

886

7970

1.11

2.19

2.4

6423.05

6247.30

u/l

0.05

340

3144

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

593

1.38

2.18

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

131

1003

1.29

2.17

1.4

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

636

5621

1.13

2.16

1.7

1.6

314.89

316.66

mu/l

0.04

573

5041

(3037121) Protein [Mass/volume] in Urine

274

2278

1.19

2.14

3.3

4.1

0.38

0.35

g/l

0.15

114

1174

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

129

988

1.29

2.13

1.2

1.1

94.61

95.01

0.05

119

938

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

587

1.38

2.13

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

167

1322

1.25

2.12

2.0

2.2

132.26

133.86

g/l

0.42

102

1023

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

150

1.78

2.11

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

423

1.45

2.11

1.1

0.09

3.08

nmol/l

1.65

(3028626) Oxygen [Partial pressure] in Capillary blood

295

2473

1.18

2.10

4.2

6.6

9.46

9.36

kpa

0.40

286

2399

(3052851) Hemolysis interference index of Serum or Plasma

237

1948

1.21

2.10

2.6

2.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

368

3143

1.16

2.09

2.6

3.0

93.84

128.40

ng/l

2.05

314

2773

(3023511) Choriogonadotropin [Units/volume] in Urine

479

4171

1.14

2.08

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

146

1142

1.27

2.06

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

154

1213

1.26

2.05

1.3

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

100

745

1.33

2.03

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.11

2.01

1.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

266

2221

1.19

2.00

1.3

1.5

20.59

22.16

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

594

1.37

2.00

1.2

62.65

73.72

u/l

0.34

543

(3011985) Renin [Units/volume] in Plasma

116

885

1.30

2.00

1.7

75.81

65.24

mu/l

0.20

103

812

(3016244) Insulin [Units/volume] in Serum or Plasma

127

981

1.28

1.99

3.1

3.3

39.84

25.72

mu/l

1.25

117

925

(3008536) Aspergillus sp Ab [Presence] in Serum

124

1.83

1.99

2.0

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

221

1.61

1.98

1.9

2.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

437

1.43

1.98

1.7

1.6

4.69

6.43

u/l

2.58

374

(3000764) Benzodiazepines [Presence] in Urine

848

7655

1.10

1.98

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

435

3779

1.14

1.97

1.3

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

113

862

1.30

1.95

2.9

3.1

0.69

1.33

3.66

788

(3051593) INR in Capillary blood by Coagulation assay

125

1.82

1.94

1.3

9.4

—

(40761535) Cells panel - Urine sediment

519

4567

1.13

1.93

3.1

3.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

544

4802

1.13

1.92

7.2

8.1

1.29

1.34

mmol/l

0.73

527

4698

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

718

1.32

1.92

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

4.49

1.92

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

155

1.72

1.91

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

751

6753

1.11

1.90

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

172

1386

1.23

1.89

1.2

1.1

118.76

115.93

0.56

154

1268

(3044009) aPTT.lupus sensitive (LA screen)

1.95

1.88

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

377

4240

0.87

1.86

1.9

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

140

1106

1.25

1.85

1.6

1.8

—

(3016879) Cocaine [Presence] in Urine

787

7106

1.10

1.84

2.1

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

670

6001

1.11

1.84

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

140

1107

1.25

1.84

1.6

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

444

1.40

1.84

1.2

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

135

1.76

1.83

1.1

—

(3048879) Bone marrow aspiration report

1.93

1.83

1.8

2.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

142

1735

0.80

1.82

4.4

5.4

0.94

0.92

0.25

130

1619

(3015350) Toxocara sp Ab [Presence] in Serum

4.11

1.80

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3580

34162

1.06

1.79

2.5

—

(3028433) Virus identified in Specimen by Culture

259

1.53

1.79

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

174

1414

1.22

1.78

1.1

104.98

6921.53

iu/ml

0.64

392

(3000093) Morphology [Interpretation] in Blood Narrative

556

1.35

1.78

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.95

1.78

1.8

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

728

1.30

1.77

1.4

1.3

19.74

33.89

u/l

1.24

625

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

634

1.33

1.76

1.7

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

729

1.30

1.75

3.6

3.3

—

(3033799) Differential panel - Peritoneal fluid

134

0.37

1.74

1.0

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

644

1.32

1.74

1.2

—

(3036603) Volume of Urine

383

1.42

1.73

1.6

1.5

2314.35

2077.92

0.88

375

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

383

1.42

1.73

1.9

1.8

2.94

3.33

mg/l

0.32

367

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

145

1754

0.81

1.71

4.4

5.3

1.57

1.77

2.11

131

1635

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

612

1.33

1.70

1.5

1.7

42.90

52.70

1.34

394

(3006922) Hepatitis E virus Ab [Presence] in Serum

647

1.31

1.69

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.20

1.68

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

109

848

1.27

1.67

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

981

10416

0.92

1.67

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

675

1.30

1.66

1.2

1.3

1.69

1.84

mmol/l

1.75

624

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

162

0.43

1.65

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

180

1482

1.20

1.64

1.3

3.74

3.86

u/ml

0.03

522

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

471

1.36

1.64

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

471

1.36

1.64

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

471

1.36

1.64

1.6

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

217

1.55

1.64

2.0

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

217

1.55

1.64

2.0

2.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

635

5711

1.10

1.64

4.4

5.5

5.84

5.85

kpa

0.14

608

5544

(3045414) Leukocytes [Presence] in Urine

354

3078

1.14

1.63

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

177

1457

1.20

1.62

1.7

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1050

9664

1.08

1.62

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

756

1.28

1.61

1.8

1.9

64.43

70.13

mmol/l

0.50

622

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

490

1.35

1.60

1.2

—

(3027944) Amphetamines [Presence] in Urine

834

7607

1.09

1.60

1.8

2.0

—

(4281824) Cell count and differential, peritoneal fluid

643

0.70

1.59

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

255

2172

1.16

1.58

1.8

2.1

38.43

4.36

iu/l

0.49

896

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

136

1094

1.23

1.58

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

276

1.47

1.56

1.3

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.96

1.56

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

963

8850

1.08

1.55

1.4

1.5

—

(3020491) Glucose [Moles/volume] in Blood

562

1.32

1.54

1.7

1.5

6.46

6.00

mmol/l

0.47

443

(3002032) Base excess in Venous blood by calculation

628

5669

1.10

1.52

4.4

5.6

1.73

1.60

mmol/l

0.42

531

4691

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

247

2106

1.16

1.52

1.3

1.6

97.19

105.77

u/ml

0.66

388

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

650

1.29

1.52

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

470

1.35

1.51

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

1.51

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

130

1047

1.23

1.50

1.7

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

114

1.73

1.50

1.0

1.1

0.58

0.70

umol/24h

0.86

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

591

5325

1.10

1.50

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.56

1.49

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

627

1.29

1.47

2.9

3.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

123

1484

0.82

1.46

3.1

3.6

122.93

1190.73

u/ml

0.92

104

1273

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

588

5304

1.10

1.46

1.4

—

(3003694) ABO and Rh group [Type] in Blood

2586

26490

0.95

1.46

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

117

1416

0.81

1.44

1.4

1.5

6.35

6.69

mmol/l

1.06

107

1295

(3050794) Legionella sp Ab [Presence] in Serum

2.04

1.44

1.3

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

253

2172

1.15

1.44

1.3

1.7

404.23

453.44

mg/l

1.03

242

2075

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.09

1.42

1.4

3.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

103

815

1.25

1.42

1.4

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

239

2713

0.87

1.42

5.8

6.9

23.96

24.28

mmol/l

0.81

223

2579

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

103

816

1.25

1.40

1.4

1.5

375.69

553.33

pmol/l

0.67

727

(3049717) Cytology report of Urine Cyto stain

142

1165

1.21

1.39

2.1

2.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.95

1.38

1.1

—

3.25

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

100

792

1.25

1.37

1.2

1.3

—

nmol/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

243

2089

1.15

1.37

1.8

2.0

1.30

1.38

g/l

0.80

209

1797

(3000330) Specific gravity of Urine by Test strip

238

2694

0.87

1.37

2.4

2.7

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.38

1.36

1.3

3.6

4.13

4.57

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1089

10113

1.07

1.35

2.0

1.9

—

(3051651) Icteric interference index of Serum or Plasma

454

1.33

1.35

2.9

3.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

733

1.25

1.34

1.6

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

490

1.31

1.32

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

312

1.39

1.32

1.0

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

194

1646

1.17

1.31

5.8

6.5

1098.42

563.13

iu/ml

0.50

200

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

588

5336

1.09

1.31

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

147

0.47

1.31

2.4

5.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

588

5340

1.09

1.29

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

135

1.61

1.29

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.73

1.29

1.5

1.4

—

166.29

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

111

897

1.22

1.29

2.0

1.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.32

1.28

1.4

—

(3044007) Cell count panel - Peritoneal fluid

130

0.46

1.28

2.2

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

105

1.69

1.27

1.7

—

(3008295) Osmolality of Serum or Plasma

677

1.26

1.27

2.5

1.7

283.26

285.79

mosm/kgh2o

0.48

538

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

168

1.53

1.24

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

233

1.44

1.24

2.3

2.5

1.70

1.60

mmol/l

0.09

177

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

137

1.59

1.23

1.1

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

167

1411

1.17

1.21

3.0

23.22

24.34

mg/l

0.14

865

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

450

0.70

1.21

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

183

1558

1.16

1.21

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

140

0.49

1.20

2.4

5.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.60

1.20

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.83

1.19

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

1.63

1.19

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

116

952

1.21

1.18

2.7

3.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

327

2902

1.12

1.17

2.7

3.8

95.65

94.76

0.32

312

2804

(3013762) Body weight Measured

0.00

1.16

0.0

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

757

1.23

1.16

1.5

—

(40763590) HLA-DQ beta [Type]

0.00

1.15

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

1.15

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

1.15

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

1.15

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

1.15

0.0

1.0

—

(3044941) Cell count panel - Synovial fluid

785

1.22

1.14

1.4

1.5

—

(3001729) Color of Synovial fluid

0.00

1.13

0.0

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

205

1.45

1.13

1.0

820.50

815.46

ng/l

0.03

141

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

117

1.60

1.12

1.1

1.8

90.45

30.25

ng/l

0.51

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

297

2629

1.12

1.2

1.3

—

(3047181) Lactate [Moles/volume] in Blood

139

1608

0.85

1.12

4.3

5.6

1.16

1.23

mmol/l

0.69

123

1409

(3009871) Measles virus Ab [Titer] in Serum

323

1.35

1.11

1.8

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

535

4879

1.09

1.11

4.0

5.3

4.90

kpa

0.01

513

4729

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

207

1.43

1.08

1.0

40.21

41.19

ng/l

0.05

143

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

385

1.31

1.07

1.5

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.35

1.07

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

481

1.27

1.07

2.6

2.7

1.82

1.62

g/24h

0.15

271

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

259

1.37

1.04

1.5

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

220

1926

1.13

1.02

1.2

1.6

3.48

3.59

mmol/l

1.27

208

1807

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.24

1.01

1.2

2.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

202

1.42

1.01

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

983

0.82

1.00

1.8

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.81

0.99

1.1

1.40

1.67

umol/24h

0.54

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

133

0.52

0.98

8.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

322

1.32

0.98

2.4

2.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.86

0.97

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

1.54

0.97

1.4

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

357

1.30

0.97

1.5

1.3

161.87

156.47

mmol/24h

0.15

357

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.97

0.0

1.9

—

0.14

—

(3019230) Fractional oxyhemoglobin in Venous blood

1063

0.83

0.96

8.7

5.6

65.40

65.57

0.03

1058

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.78

0.95

2.3

2.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

112

940

1.18

0.94

1.6

2.0

1.61

1.73

mmol/l

0.98

112

922

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

620

5735

1.07

0.93

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

751

1.20

0.93

1.1

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

652

1.21

0.93

1.3

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

105

878

1.18

0.93

1.5

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

422

1.26

0.91

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

755

0.81

0.91

8.7

11.6

0.56

0.60

mmol/l

0.89

692

(3018572) Chloride [Moles/volume] in Blood

1003

0.84

0.91

5.0

7.3

105.92

105.39

mmol/l

0.58

895

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.12

0.90

2.2

2.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

1.45

0.90

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

134

1146

1.16

0.90

2.7

3.4

—

(3039000) Anion gap in Blood

1002

0.84

0.90

5.0

7.3

11.70

11.29

mmol/l

0.64

894

(40768795) Lymph node Pathology biopsy report

590

0.79

0.90

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

327

1.30

0.90

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1074

0.84

0.88

2.8

3.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

466

0.76

0.87

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2323

22280

1.04

0.87

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

159

1.43

0.86

1.1

—

(3004451) EKG impression Narrative

184

1.40

0.86

1.3

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

787

1.18

0.84

1.7

1.9

91.62

91.11

0.60

776

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

106

897

1.17

0.83

1.2

31.24

37.44

mg/l

1.55

742

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

102

861

1.17

0.83

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

380

4050

0.92

0.82

3.2

4.0

4.71

27.31

ug/l

1.72

269

3008

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

518

1.22

0.82

1.4

1.47

1.36

nmol/l

0.31

467

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

563

1.21

0.82

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

315

1.29

0.81

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.72

0.81

1.1

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

273

2949

0.91

0.81

1.9

2.6

0.20

0.22

e6/l

0.15

261

2842

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.73

0.80

1.5

1.2

—

(3011648) Oxygen content in Venous blood

547

0.79

0.80

8.2

7.6

11.34

0.00

547

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.79

1.4

2.1

0.64

0.88

u/field

0.26

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

639

1.19

0.78

1.2

1.1

1.06

ratio

0.18

230

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.65

0.77

3.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.70

0.76

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

102

869

1.16

0.76

1.1

208.13

224.43

mg/l

0.79

765

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

806

1.17

0.75

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

465

0.78

0.75

3.0

2.9

100.99

76.93

mg/l

0.20

352

(3026008) Bacteria identified in Urine by Culture

1977

18965

1.04

0.74

2.5

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

123

1065

1.14

0.74

1.6

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

156

1.39

0.74

1.5

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

540

0.80

0.73

3.4

3.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

158

0.62

0.73

1.2

4.9

1.21

1.20

mmol/l

—

146

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.82

0.73

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.62

0.72

1.0

1.1

—

(3012565) Volume of 24 hour Urine

322

1.26

0.71

2.0

2.2

2322.42

2034.20

0.87

301

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1433

13679

1.04

0.71

2.1

2.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

331

1.25

0.71

1.4

1.8

0.15

0.21

nmol/l

0.90

248

(3004446) Plasmodium sp identified in Blood by Light microscopy

124

1.43

0.70

3.0

2.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

116

1.45

0.70

1.4

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

556

1.19

0.70

4.6

3.9

9.07

8.19

mg/l

0.57

443

(3041096) Erythrocytes [Presence] in Urine by Automated

2217

21337

1.03

0.70

2.6

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.50

0.68

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.53

0.68

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

118

1027

1.14

0.68

1.1

—

19.53

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

631

1.17

0.67

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.83

0.67

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.65

0.67

1.7

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

159

1411

1.11

0.67

1.2

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.53

0.66

1.2

1.1

—

3.87

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

514

1.19

0.66

2.8

3.3

107.64

139.78

au/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

281

2996

0.92

0.66

4.6

4.4

134.74

132.20

g/l

1.23

273

2938

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

215

1940

1.10

0.66

1.3

1.8

429.06

3073.91

e6/l

0.76

174

1561

(3050129) First trimester maternal screen panel - Serum or Plasma

676

7001

0.95

0.65

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

257

1.27

0.63

1.5

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

319

1.24

0.63

2.1

1.78

1.37

nmol/l

1.12

264

(3023183) Ammonium ion [Moles/volume] in Plasma

116

1289

0.89

0.63

3.4

3.1

35.13

34.69

umol/l

0.05

108

1217

(3022621) pH of Urine by Test strip

462

4304

1.06

0.63

2.5

—

(40767503) Oxygen content in Capillary blood by calculation

136

1202

1.12

0.63

2.4

17.33

17.34

0.01

599

(3016018) Differential panel - Cerebral spinal fluid

116

1016

1.13

0.62

1.3

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

214

1940

1.09

0.61

1.3

1.8

14.97

23.80

e6/l

0.66

164

1489

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.60

0.0

6.1

—

930.64

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.60

0.0

1.2

—

1.57

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

110

963

1.13

0.60

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

259

1.26

0.60

1.4

1.9

—

18835.65

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.60

0.0

6.1

—

(3023410) Appearance of Cerebral spinal fluid

114

1001

1.13

0.59

1.4

2.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2941

28500

1.03

0.59

3.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

116

1021

1.12

0.58

2.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.52

0.58

3.5

3.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

217

0.73

0.58

1.7

2.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.74

0.58

1.0

—

24.00

—

(3020650) Glucose [Presence] in Urine

239

0.74

0.57

1.2

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

425

0.81

0.57

1.6

2.9

98.14

180.97

umol/l

1.92

224

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1091

0.89

0.56

2.3

2.5

75.14

136.42

ug/min

1.08

710

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

315

1.22

0.56

1.3

1.5

13.60

14.24

pmol/l

0.42

266

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

351

1.21

0.56

1.3

1.2

90.03

84.43

u/l

0.14

310

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.51

0.56

2.5

2.2

5.72

7.09

mmol/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

326

0.79

0.56

1.5

2392.12

2927.52

e6/l

0.21

223

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

253

2321

1.08

0.56

1.5

0.44

0.42

nmol/l

0.06

210

1890

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

215

0.73

0.55

2.8

2.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

218

1.27

0.55

1.1

—

(40757373) Influenza virus identified in Isolate

114

1.39

0.55

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

112

1234

0.89

0.55

7.5

5.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.60

0.55

1.2

1.4

359.52

521.23

nmol/l

—

(3001186) Copper [Moles/volume] in Serum or Plasma

245

1.25

0.54

1.3

1.4

17.54

16.96

umol/l

0.32

224

(21494434) Karyotype in Bone marrow

407

1.19

0.54

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

443

0.82

0.53

5.7

7.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.56

0.53

1.2

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.56

0.53

1.2

1.3

—

(4034850) Laboratory test

218

1993

1.08

0.53

6.7

7.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

536

1.16

0.53

1.1

1.2

1.54

1.55

g/l

0.15

536

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.49

0.53

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.53

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

259

2385

1.07

0.53

4.5

8.8

1.20

1.23

mg/l

0.23

245

2294

(40761536) Microorganisms panel - Urine sediment

708

6714

1.04

0.52

3.6

3.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.52

0.52

6.5

5.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

430

0.83

0.51

2.5

2.6

56.00

51.64

umol/l

0.39

396

(42529582) MDA5 Ab [Presence] in Serum by Line blot

142

1.32

0.50

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

142

1.32

0.50

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

142

1.32

0.50

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

142

1.32

0.50

1.3

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

338

1.20

0.50

1.4

1.6

1.13

3.48

u/field

2.24

249

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

342

0.81

0.50

1.0

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

320

0.80

0.49

7.1

6.1

7219.00

519.04

mg/l

0.44

247

(44816559) Phosphatidylethanol [Mass/volume] in Blood

221

2032

1.08

0.48

1.2

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

135

1458

0.91

0.48

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

313

1.20

0.48

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

250

1.22

0.47

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

250

1.22

0.47

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

250

1.22

0.47

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

197

0.75

0.47

1.7

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

144

1.30

0.47

7.3

4.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

832

1.12

0.47

1.5

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

481

4967

0.95

0.46

7.7

9.1

6.89

7.12

mmol/l

0.43

458

4795

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

435

0.84

0.46

7.0

6.0

—

(3041354) Potassium [Moles/volume] in Venous blood

435

0.84

0.46

1.6

2.2

3.99

3.95

mmol/l

0.33

430

(40761995) Spermatozoa Progressive [#/volume] in Semen

435

0.84

0.46

3.5

3.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

833

1.12

0.46

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

288

1.20

0.45

1.5

2.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

288

1.20

0.45

1.5

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

453

1.16

0.45

1.4

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

433

0.84

0.44

1.6

2.2

107.49

105.66

mmol/l

2.80

428

(3042733) HLA Ab [Presence] in Serum

304

0.81

0.44

6.6

4.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.38

0.44

2.3

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1144

10991

1.03

0.44

2.0

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

353

1.18

0.43

1.5

1.6

7.59

5.94

u/l

0.37

297

(3022689) Creatine [Moles/volume] in Urine

172

0.75

0.43

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

473

1.15

0.43

1.3

1.7

39.70

38.19

0.09

291

(3009466) Valproate [Moles/volume] in Serum or Plasma

114

1233

0.91

0.43

5.3

5.6

369.54

384.52

umol/l

0.62

101

1091

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.59

0.42

1.8

1.1

0.03

mg/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.59

0.42

1.6

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.66

0.42

1.0

180.17

164.01

g/l

—

(3028717) Thiamine [Mass/volume] in Blood

0.64

0.42

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

624

1.12

0.41

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

727

1.11

0.41

1.8

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

346

1.17

0.41

2.0

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

471

0.86

0.41

1.5

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.2

—

1.11

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.35

0.41

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

130

1.29

0.40

1.2

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

0.00

0.40

0.0

1.2

—

34.45

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.40

0.0

1.1

—

210.41

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

784

0.89

0.40

1.5

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

393

1.16

0.40

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

120

1288

0.92

0.40

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.32

0.39

1.4

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1020

0.91

0.39

1.4

34.70

31.19

nmol/l

0.63

940

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.41

0.39

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

239

1.20

0.38

5.0

3.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

222

0.80

0.37

3.3

1.6

—

513.00

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

341

1.16

0.37

2.2

2.3

170.97

125.40

ng/l

1.60

262

(3014051) Protein [Presence] in Urine by Test strip

185

1714

1.07

0.36

2.6

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

772

1.10

0.36

1.3

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.44

0.35

1.7

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.66

0.35

1.0

1.3

—

(3035880) pH of Pleural fluid

124

1.27

0.35

1.2

1.3

—

(42870560) Thyrotropin [Units/volume] in Cord blood

278

1.17

0.35

1.0

8.84

8.82

mu/l

0.01

227

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.41

0.35

1.7

1.1

—

(3016502) Oxygen saturation in Arterial blood

476

4529

1.04

0.35

7.4

8.8

95.38

96.20

1.17

457

4367

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

343

1.15

0.35

1.3

1.2

13.71

17.86

u/l

0.56

300

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

427

1.13

0.34

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

347

0.85

0.34

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.35

0.34

1.2

—

(3017509) Phencyclidine [Presence] in Urine

188

1.21

0.34

1.6

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

1290

1.07

0.33

3.0

4.7

1795.50

1019.63

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.70

0.33

1.3

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

504

1.12

0.32

1.2

11.86

17.82

u/ml

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.29

0.32

1.2

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

420

1.13

0.32

1.4

22086.18

42763.49

e6/l

0.52

298

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

195

1820

1.06

0.32

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

418

0.87

0.32

1.6

2.2

—

(4035726) Immunohistochemistry procedure

471

4812

0.96

0.32

1.4

—

(3007916) DNA double strand Ab [Titer] in Serum

1.32

0.31

1.3

—

332.39

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

141

0.77

0.31

1.2

4.9

1.22

1.21

mmol/l

0.42

128

(40768793) Breast Pathology biopsy report

167

1554

1.06

0.31

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

282

1.16

0.31

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

127

1.24

0.30

1.5

19.67

16.64

nmol/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

147

1543

0.94

0.30

1.5

1.6

7.49

7.57

mmol/l

0.21

142

1483

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

256

2645

0.95

0.30

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

292

1.15

0.30

1.5

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

173

1.20

0.29

1.2

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

293

1.15

0.29

1.3

6.44

6.14

mmol/l

0.27

270

(3011048) Pyruvate [Moles/volume] in Blood

119

1.24

0.29

1.1

1.4

102.80

86.84

umol/l

0.35

111

(3045788) Cell count panel - Pleural fluid

267

0.85

0.29

1.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1981

19286

1.02

0.28

3.4

0.00

estimate

0.13

707

7201

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

223

2306

0.95

0.28

5.0

4.3

0.69

0.66

0.76

223

2295

(3016750) Collection duration of Urine

287

0.86

0.28

1.6

2.3

525.50

507.53

min

0.36

231

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

129

1.22

0.27

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

398

1.12

0.27

1.6

2.0

1.96

1.92

u/field

0.02

213

(3004775) Volume in Urine collected for unspecified duration

349

0.88

0.27

1.8

2.4

670.00

621.88

0.28

264

(3003434) Protein [Mass/volume] in Pleural fluid

328

0.87

0.27

1.4

1.5

36.53

36.00

g/l

0.09

294

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

380

1.12

0.26

1.1

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

157

1.19

0.26

1.4

2.2

1.83

4.10

nmol/l

1.09

146

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

452

0.89

0.26

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

405

4127

0.97

0.26

2.3

2.6

30.61

37.67

u/ml

0.62

394

3993

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

264

0.86

0.26

1.2

1.0

19.60

19.85

mmol/l

0.17

248

(3006653) Thiamine [Moles/volume] in Blood

334

1.12

0.26

1.3

1.4

131.42

132.45

nmol/l

0.06

334

(3022670) pH of Venous cord blood

0.67

0.25

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.26

0.25

1.1

1.0

—

(3020891) Body temperature

182

1885

0.95

0.25

3.7

4.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

140

1.20

0.24

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

763

1.07

0.24

1.5

1.41

1.34

promille

0.16

577

(3006598) pH of Arterial cord blood

241

0.86

0.24

1.1

1.0

—

(3012898) Urea [Moles/volume] in Urine

1.28

0.24

1.9

1.8

220.70

176.13

mmol/l

—

(3045142) Bone marrow Pathology biopsy report

554

1.09

0.23

1.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

266

2532

1.04

0.23

8.8

11.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.73

0.22

1.1

1.4

62.00

55.59

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

557

5628

0.98

0.22

2.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

671

1.07

0.22

1.6

2.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

230

2357

0.96

0.22

4.9

4.3

1.37

1.36

0.03

230

2343

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

155

1461

1.05

0.21

1.3

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

1.0

—

1.10

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1812

18091

0.99

0.21

1.6

1.5

—

(21494755) Public health laboratory ask at order entry panel

1177

11791

0.98

0.21

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.18

0.21

2.4

2.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.21

1.4

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

154

0.83

0.21

1.8

4.4

—

(3008607) Semen analysis panel

115

1.20

0.21

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

100

0.79

0.21

3.0

5.3

—

(3047189) Immunofixation for 24 hour Urine

152

1.17

0.21

3.3

1.7

—

(3017704) Immunofixation for Urine

180

1.15

0.21

1.7

1.6

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.20

0.0

4.2

—

138.92

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.20

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

454

0.91

0.20

1.3

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

134

1.18

0.20

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

216

0.87

0.20

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

3.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

550

1.08

0.20

2.4

2.2

—

(1761868) Lipid panel - Serum or Plasma

3014

29525

1.01

0.19

2.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

215

0.87

0.19

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

1390

1.04

0.19

1.5

2.7

0.86

0.78

nmol/l

0.55

121

1194

(3014148) Varicella zoster virus Ab [Titer] in Serum

184

1749

1.04

0.19

1.2

—

(3002619) Bacteria identified in Specimen by Culture

163

1.15

0.19

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.14

0.19

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

267

1.11

0.18

1.4

1.6

2.40

5.11

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

234

0.89

0.17

2.8

2.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

693

0.94

0.17

2.7

4.6

7.78

7.06

mmol/l

0.59

569

(3027801) Oxygen [Partial pressure] in Arterial blood

532

5150

1.02

0.17

7.2

8.1

13.02

13.74

kpa

2.33

503

4935

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

532

5151

1.02

0.17

7.2

8.1

5.04

5.06

kpa

0.28

505

4937

(40768800) Prostate Pathology biopsy report

377

0.92

0.17

1.1

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

193

1.13

0.16

5.9

3.7

46.48

48.04

0.13

188

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

202

0.88

0.16

1.9

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

462

4469

1.02

0.16

3.0

3.7

1.23

mmol/l

0.20

409

3911

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

100

1.18

0.16

2.6

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

470

1.07

0.16

1.0

101.36

92.46

1.14

379

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.14

0.15

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

126

1293

0.96

0.15

4.1

6.2

0.37

0.33

u/ml

0.64

719

(3026470) Cobalt [Mass/volume] in Blood

169

0.88

0.15

2.4

2.0

2.63

2.78

ug/l

0.11

155

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.81

0.14

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.78

0.14

1.0

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

423

4254

0.98

0.14

7.8

8.9

125.42

123.92

g/l

0.77

412

4143

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

137

0.86

0.14

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

111

1.16

0.13

2.5

2.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

481

4668

1.02

0.13

2.5

2.4

80.98

78.19

ml/min/173m2

0.84

209

1655

(3006442) Creatine [Moles/volume] in Serum or Plasma

474

1.06

0.13

1.3

1.4

77.41

73.51

umol/l

0.44

474

(3005033) Fetal Nuchal fold Thickness US

439

4258

1.02

0.13

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

440

4269

1.02

0.13

1.4

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

225

2166

1.03

0.13

3.0

3.8

25.27

25.07

mmol/l

0.41

211

2089

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

157

0.88

0.13

1.1

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

157

0.88

0.13

1.1

3.0

—

(3025577) Chromium [Mass/volume] in Blood

167

0.89

0.13

2.4

2.0

2.05

2.57

ug/l

0.47

146

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

216

1.10

0.12

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

678

1.05

0.12

7.5

7.7

10.39

10.42

mg/l

0.02

635

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

354

3561

0.98

0.12

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

278

0.92

0.11

1.4

1.5

—

(3003338) MCHC [Mass/volume]

7299

72176

0.99

0.11

13.3

12.9

333.84

333.62

g/l

1.38

7246

71593

(3010937) Rubella virus Ab [Presence] in Serum

1.16

0.11

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.16

0.11

1.5

1.6

119.55

88.14

ng/l

0.32

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

137

1392

0.97

0.11

2.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

362

1.06

0.11

3.1

0.80

0.81

nmol/l

0.07

279

(3043238) Trisomy 21 risk [Likelihood] in Fetus

449

4368

1.02

0.11

1.5

—

(40768446) Kidney Pathology biopsy report

348

0.94

0.11

1.8

—

(3025130) Human papilloma virus identified in Specimen

171

1646

1.03

0.11

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

324

1.07

0.10

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

175

0.90

0.10

4.0

6.2

23.11

24.62

mmol/l

1.10

168

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

134

0.88

0.10

1.4

—

(3003396) Base excess in Arterial blood by calculation

530

5166

1.01

0.10

7.2

8.1

0.57

0.74

mmol/l

0.60

427

4010

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

154

0.90

0.10

1.1

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

175

1688

1.02

0.10

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

567

1.04

0.10

1.2

1.1

0.99

1.02

u/l

0.31

247

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

558

0.95

0.10

1.1

1269.11

1492.74

miu/ml

1.02

558

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.05

0.09

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

285

0.93

0.09

1.4

1.5

6575.93

66278.44

e6/l

1.49

163

(3024471) HLA-A [Type]

315

0.94

0.09

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

0.89

0.08

1.5

1.2

—

(40768806) Pleura Pathology biopsy report

274

0.94

0.08

1.6

1.5

—

(3036180) Methadone [Presence] in Urine

872

1.03

0.08

2.2

2.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

144

1.10

0.08

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

0.78

0.08

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

231

1.07

0.08

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.85

0.07

9.5

7.4

5.78

6.00

mmol/l

—

(3024932) HLA-DR beta [Type]

313

0.95

0.07

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

222

1.07

0.07

1.3

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.07

0.07

1.3

1.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.87

0.07

1.1

1.4

23.43

29.29

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.86

0.07

1.1

1.4

4.43

3.54

—

(21494814) CD8 cells/100 lymphocytes in Specimen

300

1.05

0.07

2.1

2.3

—

(40768441) Liver Pathology biopsy report

554

1.03

0.06

1.2

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

104

0.85

0.06

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

829

0.98

0.06

3.3

4.4

109.55

85.29

u/ml

0.13

281

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

430

0.96

0.05

1.1

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

205

1.06

0.05

1.0

1.1

—

180.00

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

205

1.06

0.05

2.8

2.7

25.90

29.07

umol/l

0.76

143

(3019150) Specific gravity of Urine by Refractometry

1639

16123

1.00

0.05

3.1

3.3

1.02

kg/l

0.02

235

2336

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

270

2638

1.01

0.05

1.3

4.12

3.96

ug/l

0.11

254

2468

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

313

1.04

0.05

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

747

0.98

0.05

2.9

3.7

167.92

603.42

u/ml

0.67

696

(3000012) Reticulocyte production index

538

0.97

0.04

1.6

2.2

—

(3019060) Gas panel - Arterial blood

269

2680

0.99

0.04

3.7

5.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

431

1.03

0.04

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

148

1.07

0.04

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

138

0.93

0.04

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

148

0.93

0.04

1.0

—

(3042517) Benzodiazepines panel - Urine

208

0.95

0.04

2.2

2.4

—

(40765096) Chromosome analysis panel by Banding

158

1.06

0.04

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

200

1994

0.99

0.04

1.4

66.82

104.04

pmol/l

1.66

194

1941

(3024263) Appearance of Synovial fluid

256

1.04

0.03

1.4

1.6

—

(3015183) Erythrocyte sedimentation rate

555

0.98

0.03

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

444

1.02

0.02

2.4

2.8

44.49

44.27

0.03

237

(3022229) Phosphate [Moles/volume] in Urine

160

1.05

0.02

3.8

2.9

26.49

19.75

mmol/l

1.22

146

(3019832) Treponema pallidum Ab [Presence] in Serum

1868

18463

1.00

0.02

1.7

1.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

141

1.05

0.01

1.2

1.7

3.16

3.93

ug/l

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

157

1560

0.99

0.01

1.8

2.0

1.14

1.98

ug/l

1.58

136

1402

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

230

1.03

0.01

1.1

—

(3019977) pH of Arterial blood

240

1.03

0.01

1.2

3.0

7.42

7.43

—

(3034426) Prothrombin time (PT)

329

1.02

0.01

1.2

—

(40758292) HTLV I+II Ab panel - Serum

172

1.03

0.00

1.7

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

172

1.03

0.00

1.8

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

529

0.99

0.00

1.3

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

118

1.00

0.00

1.2

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

120

0.99

0.00

1.1

4.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

228

1.00

0.00

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

656

0.99

0.00

1.2

1.6

—

(3016228) CD19 cells/100 cells in Blood

305

1.00

0.00

2.2

2.3

8.35

9.46

0.39

298

(3032868) Hemoglobin electrophoresis panel in Blood

127

1.01

0.00

1.5

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

124

1.03

0.00

1.5

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

226

1.00

0.00

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

215

1.01

0.00

2.1

2.2

—

(3017569) Oxygen content in Arterial blood

172

0.98

0.00

1.8

2.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

254

1.01

0.00

1.1

1.2

—

0.14

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

132

0.97

0.00

1.2

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

0.97

0.00

1.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

52.33

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.6

—

723.30

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.91

-0.00

2.8

1.8

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

2.1

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

2.06

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.94

-0.00

4.4

4.7

—

(3049233) Organic acids panel - Urine

0.91

-0.00

1.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.99

-0.00

1.8

4.9

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.95

-0.00

2.4

1.2

—

551.42

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

6.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.94

-0.00

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.90

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint POLLENALLERG and mortality.

Females

Parameter	HR [95% CI]	p-value
POLLENALLERG	0.829 [0.7, 0.98]	0.031
Birth year	0.998 [0.99, 1.01]	0.672

During the follow-up period (1.1.1998 — 31.12.2019), 503 out of 42785 females with POLLENALLERG died.

Males

Parameter	HR [95% CI]	p-value
POLLENALLERG	0.69 [0.59, 0.81]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 571 out of 48491 males with POLLENALLERG died.

Mortality risk

Mortality risk for people of age

years, who have POLLENALLERG.

N-year risk	Females	Males
1	0.073%	0.129%
5	0.511%	0.928%
10	1.317%	2.246%
15	2.714%	4.4%
20	4.576%	7.364%

Relationships between endpoints

↥

Index endpoint: POLLENALLERG – Pollen allergy

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pollen allergy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints